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1 Introduction 
 
1.1 Epidemiological Background 
 
The prevalence of atopic diseases continues to rise in industrialised countries. In the 
search for possible causes, attention has been focused on factors related to Western 
lifestyle, including dietary habits. 1-2  
It was suggested that the observed increase in the consumption of polyunsaturated 
fatty acids (PUFA) during the 20th century, due to the wider use of fat from vegetable 
origin, might have contributed to the observed increase in allergy prevalence.2-3 The 
supply of omega-6 fatty acids such as linoleic acid may increase arachidonic acid 
intake, which enhances the formation of pro-inflammatory cytokines and of 
immunoglobulin E (IgE).2-4-5-6 Available epidemiological evidence is often gender 
specific;7-8-9 whether these gender differences might be related to known sex-specific 
dietary habits or not is highly speculative. Margarine may contain several-fold higher 
amounts of n-6 fatty acids than butter.9 Thus, in a study conducted in adult women, 
dietary intake of n-6 fatty acids was positively associated with hay fever.9 A European 
ecological study found no associations between polyunsaturated fatty acids 
consumption and sensitisation, but supported the hypothesis that a high intake of 
monounsaturated fatty acids (MUFA) may lead to the development of atopic disease.10 
Epidemiological studies conducted in children revealed an inverse association between 
high fish consumption, which provides long chain omega-3 fatty acids, and the 
prevalence of asthma and bronchial hyperresponsiveness, thus inferring that a 
decreased omega-6 to omega-3 ratio attenuates the inflammatory immune reaction.8-11  
A number of studies have reported an association between dietary antioxidants, 
asthma and atopy.12 The National Health and Nutrition Examination Study (NHANES) 
demonstrated negative associations between the prevalence of wheeze and serum 
levels of vitamin C, niacin, zinc and copper. 13-14 
Investigators pinpointed marked changes in the United Kingdom population’s diet 
occurring since the 1960’s, with a negative trend in fresh food consumption, particularly 
the consumption of fresh green vegetables. Based on that fact, it was hypothesized that 
the recent increase in asthma and atopy might be associated with the declining dietary 
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intake of fresh fruit and vegetables, being the consequently low antioxidants intake the 
plausible biological explanation.15 Further evidence available from a European 
ecological study revealed a protective effect of high fruit consumption on allergic 
sensitisation prevalence.10 Additionally, current results from a cross-sectional study 
confirmed that the intake of some vegetables may decrease the prevalence of adult 
asthma.16 Among children, consumption of fresh fruit, particularly fruit high in vitamin C, 
has been related to a lower prevalence of asthma symptoms at young ages and higher 
lung function in children and adults.17-18 
In addition, the Nurses’ Health Study demonstrated a negative association between 
asthma and food containing vitamin E.19 Also, a recent study showed a negative 
association between serum IgE levels as well as allergen skin prick test sensitisation 
and the intake of foods rich on vitamin E.20 
Moreover, evidence from a nested case control study confirmed a significantly 
higher risk of bronchial hyper reactivity among those with the lowest intake of vitamin E 
and vitamin C, carbohydrate and fiber, while the lowest intake of saturated fats gave a 
ten-times higher protection. The same study group linked an increased risk of adult 
onset asthma with a low intake of vitamin E and vitamin C. These results were 
supported by direct measurements of plasma vitamins and triglycerides.21-22 In addition, 
low β-carotene intakes have also been associated with allergic rhinitis.23 
Ongoing research is focusing on the possibility that maternal antioxidants and lipid 
intake influences fetal immunity, and therefore the likelihood of childhood asthma and 
atopic disease.24 Evidence from a recent clinical study in neonates indicates that altered 
membrane PUFA profiles during gestation may influence immunological function.25 
Higher maternal intake of foods containing vitamin E and zinc during pregnancy has 
been associated with decreased risk of developing childhood wheeze, asthma and 
atopic eczema.26 
Although intake of fat, vegetable, and fruit as well as other related nutrients were 
associated with prevalence rates of allergic sensitisation, hay fever, and asthma in a 
few studies, the findings were not consistent in relation to specific nutrients. 
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1.2 Study Objectives 
 
The amount and type of dietary fat and antioxidants consumed may be related to the 
prevalence of atopic disease. This is a cross sectional study using data collected in the 
city of Erfurt on German adults, aiming to explore whether: 
 
1. The consumption of selected food, specifically fat, fruit and vegetable intake is 
related to the prevalence of atopic disease. 
2. The intake of specific fatty acids shows any association with the prevalence of 
asthma, bronchial hyperresponsiveness, allergic sensitisation, hay fever and/or 
atopic eczema. 
3. The amount of ingested antioxidants could be linked to atopic disease 
prevalence. 
4. Any gender related differences between dietary intake and atopic disease 
prevalence are evidenced in the analysed population. 
 
1.3 Mechanisms of Allergic Disease 
 
Normally the immune system clears antigens without any adverse reactions. Three 
types of cells are involved in this response to antigens: B-lymphocytes, T-lymphocytes 
and macrophages. The lymphocytes arise from the bone marrow and are the basis for 
the functioning of two branches of the immune system: the humoral pathway and the 
cell-mediated pathway. 
The humoral pathway involves antibodies (Ig). Antigen-specific antibodies are 
produced by the B-lymphocytes (B-cells) in response to the external antigen presented. 
The union of an antigen and an antibody causes the production of chemical mediators 
and/or direct cellular damage that triggers clinical manifestations. 
Five antibody classes have been identified: IgG, IgM, and IgD antibodies protect the 
organism against bacteria and viruses. Secretory IgA antibodies in breast milk provide 
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local intestinal protection for infants against viruses and bacteria (Laurence, 1985) IgA 
are also present in saliva and intestinal secretions, blocking the antigen’s absorption. 
Allergic reactions are usually classified into four types: Types I, II and III, which are 
antibody dependent, and type IV that is T-cell dependent. 
Type I allergic reaction involving IgE is the most common allergic reaction and has 
the most clearly understood immune mechanism.27-28-29 
 
1.4 Pathogenesis of IgE-Mediated Allergic Response 
 
The IgE antibodies play just a part in the allergic process; several other immune 
response pathways are involved. For example, asthma and allergic rhinitis among other 
allergic diseases may involve more than one immunological mechanism. 
The IgE-mediated allergic response has been described in three major steps: 
 
•
 Step 1. Sensitisation 
•
 Step 2. Early Phase Reaction 
•
 Step 3. Late Phase Reaction 
1.4.1 Step 1. Sensitisation 
The initial exposure to the allergen leads to IgE production. The antigen-
presenting cells recognize and process the antigen into antigenic peptides. The 
peptides portions are exposed to the T-lymphocytes, thus stimulating the secretion of 
cytokines. The direct interaction between the T-lymphocyte and the B-lymphocyte 
activates the antigen-specific IgE production by the B-lymphocyte. Once released, the 
IgE will be bounded by high affinity Fcε receptors (FcεR) on mast cells and/or 
basophiles.27-28 
 
1.4.2 Step 2. Early Phase Reaction (Immediate Hypersensitivity) 
A later exposure to the same allergen causes reactivation of the sensitized IgE fixed 
to tissue mast cells or circulating basophiles, which in turn causes degranulation leading 
to the release of preformed mediators, such as histamine, tryptase and heparin, along 
with new synthesized cytokines, interleukines, and leukotrienes. (Figure 1) 
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Once released, these mediators, particularly histamine, cause a series of symptoms, 
such as:  
•
 Smooth muscle constriction 
•
 Vasodilatation 
•
 Mucus secretion, and  
•
 Sensory nerve stimulation. 
 
 
 
 
Figure 1. Immediate Hypersensitivity Reaction 
Introduction 
 12 
1.4.3 Step 3. Late Phase Reaction 
The late phase reaction occurs in a variable time frame, from hours to days after 
the exposure to the allergen. It is characterized by the influx of inflammatory cells. 
(Figure 2) 
The allergen also stimulates the activation of inflammatory cells (e.g., mast cells, T-
cells) leading to the production of pro-inflammatory mediators (e.g., leukotrienes, 
cytokines). These mediators exert their action at the post-capillary endothelial cells, 
promoting: 
•
 Outflow of plasma leading to localized edema; 
•
 Adhesion of circulating leukocytes; and 
•
 Infiltration of tissues by eosinophils, neutrophils, and basophiles. 
Over the course of several hours, further inflammatory reactions will follow. The 
eosinophils produce mediators that cause tissue damage associated with chronic 
allergic reactions, e.g.: major basic protein, eosinophil cathionic protein, leukotrienes. 
Simultaneously TH2 lymphocytes release cytokines thus promoting IgE formation, 
increase of mucosal mast cells and the chemo attraction of eosinophils.27-28 
 
 
 
             
             
             
             
             
             
             
             
            
     
(A) Immediate hypersensitivity reactions occur within minutes of exposure to allergen in sensitized individuals. 
With repeat exposure to allergen, multiple IgE- FcεR-complexes are cross-linked, resulting in immediate 
hypersensitivity reactions (i.e., mast cells degranulate releasing histamine, leukotrienes, cytokines, and 
proteases). 
(B) Late reactions begin 2 to 4 hours after allergen exposure and can last for 24 hours before subsiding. 
Inflammatory leukocytes (e.g. neutrophils, basophils, eosinophils) are involved but the late response is 
primarily mediated by eosinophils in atopic individuals. These inflammatory cells release cytokines and 
chemokines during the response. 
 
Figure 2. Immediate and Late Reactions in IgE-Mediated Hypersensitivity 
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1.5 Biochemistry, Metabolism and Dietary Sources of PUFA 
 
The classification of the PUFA into n-3 and n-6 depends on the position of the last 
double bond close to their methyl end. PUFA are considered essentials based on the 
inability of mammals to neither synthesize nor convert n-3 and n-6 PUFA and also 
because they are required for cell membrane integrity and a wide variety of cellular 
functions. Dietary PUFA are subjected to elongation and desaturation.29-30 
The most common dietary fatty acids are linoleic acid (LA; 18:2 n-6), γ-linolenic acid 
(GLA; 18:3 n-6) and arachidonic acid (AA; 20:4 n-6). On the other hand, common 
dietary n-3 PUFAS comprise α-linolenic acid (ALNA; 18:3n-3) as well as 
eicosapentaenoic acid (EPA; 20:5 n-3) and docosahexanoic acid (DHA; 22:6 n-3).29-30-31 
The most abundant PUFA delivered by vegetable oil consumption is LA (18:2n-6) 
which is metabolized to AA (20:4n-6) via GLA and dihomo- γ-linolenic acid (DGLA; 
20:3n-6). AA is the precursor of prostanoids and leukotrienes (LT) known as well as 
eicosanoid messengers. Natural sources of GLA are oils from borage, blackcurrant 
seed and evening primrose (Table 1).29-30-31  
The main n-3 PUFA in vegetable oils, ALNA (18:3n-3), can not be efficiently 
converted to EPA (20:5n3) and DHA (22:6n3) in humans. Aging and disease conditions 
could also further limit the elongation and desaturation processes.  For this reason EPA 
and DHA are considered to a large extent, nutritionally essential and nearly exclusively 
derived from marine fish oils. Once ingested, PUFAS are distributed to virtually every 
body cell. FFA (free fatty acids) enter the cell and are converted to fatty Acyl-coenzyme 
A thioesters, which are substrates for elongation, desaturation, lipid synthesis, ß-
oxidation, protein acylation reactions and mediator synthesis.29-30-31 
Since PUFA cannot be synthesized by humans, the dietary PUFA content 
determines the proportion of PUFA in fatty acyl-CoA and membrane phospholipids. 
Moreover, dietary PUFA and their metabolites derived from all these reactions can 
affect cellular functions. PUFA exert both immunomodulatory and anti-inflammatory 
effects, but those of the n-3 series are considered more pronounced compared to those 
of the n-6 series.29-30-31-32-33 
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Table 1 Common fatty acids and sources 
 
Trivial name Short designation Systematic name Typical Fat Source 
Saturated fatty acids    
Palmitic acid 16:0 hexadecanoic acid Most fats and oils 
Stearic acid 18:0 octadecanoic acid Most fats and oils 
    
Monounsaturated  
fatty acids    
Palmitoleic acid 16:1n-9 9-hexadecenoic acid Beef fat, some fish oils 
Oleic acid 18:1n-9 9-octodecenoic acid Esp. olive oil, most fats 
and oils 
    
Polyunsaturated fatty 
acids,n-6    
Linoleic acid 18:2n-6 9,12-octadecadienoic 
acid 
Most vegetable oils esp. 
safflower, corn, soybean 
γ-Linolenic acid 18:3n-6 6,9,12-octadecatrienoic 
acid Primrose oil, borage oil 
Dihomo- γ-Linolenic acid 20:3n-6 8,11,14-eicosatrienoic 
acid  
Arachidonic acid 20:4n-6 5,8,11,14-
eicosatetraenoic acid Lard 
 
Polyunsaturated fatty 
acids, n-3    
α-Linolenic acid 18:3n-3 9,12,15-
octadecatrienoic acid 
Plant leaves, canola oil, 
soybean oil, Flax seed 
oil 
Eicosapentaenoic acid 20:5-n3 5,8,11,14,17-
eicosapentaenoic acid Some fish oils 
Docosahexanoic acid 22:6n-3 4,7,10,13,16,19-docosahexaenoic acid Some fish oils 
1 All double bonds of listed fatty acids are in cis configuration 
Adapted from 29-30 
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1.6 Immunomodulation by PUFA 
  
Dietary PUFA interfere with a wide spectrum of physiological and pathophysiological 
processes, thereby affecting health as well as disease. PUFA are proved to alter 
plasma lipid levels, cardiovascular function, insulin action, neuronal development, and 
specifically the function and regulation of the immune system. A variety of molecular 
mechanisms have been found to explain how PUFA could interfere with immune cell 
function. PUFA alter eicosanoid (prostaglandin, leukotriene) synthesis, orphan nuclear 
receptor activation (e.g. peroxisome proliferator-activated receptors, liver X receptors) 
and T lymphocyte signalling by changing the molecular composition of special signalling 
platforms called lipid rafts.32 
 
1.7 PUFA Effects on Lipid Messengers 
 
Non esterified PUFA are released from membrane phospholipids to synthesize 
eicosanoid mediators, e.g prostaglandins (PGs), leukotrienes (LTs) and thromboxanes. 
The phospholipase A2 releases the predominant AA from the cell membranes which 
through the action of the cyclooxigenases (COX) generates PGs and thromboxanes of 
the 2-series, e.g. PGE2 and PGF2a. The action of COX-1 and COX-2 is induced by 
activation in inflammatory cells, enhancing the production of PGs. AA metabolism via 5-
lipoxygenase (5-LOX) in monocytes and/or macrophages, granulocytes and other 
inflammatory cells produces 5-hydroxyeicosatetraenoic acid (5-HETE) and 5-
hydroperoxyeicosatetraenoic acid along with LT of the 4-series (LTA4 and LTB4).30-32-33 
Eicosanoid messengers are poorly founded in lymphocytes; nonetheless these 
messengers impact lymphocyte function by exerting anti-inflammatory effects, such as 
the inhibition of lymphocyte proliferation and the production of Th1 by the action of 
PGE2. The same PGE2 also inhibits the synthesis of TNF-α, IL-1 and IL-6 by monocytes 
and macrophages. Additionally, PGE2 exerts pro-inflammatory effects as well, for 
example, fever induction, increased vasodilatation, and vascular permeability. On the 
other hand, LTB4 acts also as pro-inflammatory by increasing vascular permeability. 
Through its chemotactic effect over the leukocytes, LTB4 promotes the release of 
lysosomal enzymes and the production of oxygen radicals as well as TNF-α, IL-1 and 
Introduction 
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IL-6. In addition, PGE2 inhibits 5-LOX, thus blocking the LTx4 synthesis and AA also 
give rise to anti-inflammatory lipoxins generated via 15-LOX. Therefore, eicosanoids 
exert pro- as well as anti-inflammatory actions. GLA is elongated to DGLA, leading to 
the formation of the 1-series of PGs and the 3-series of LT. 32-33 
Compare to AA, EPA and DHA are poor COX and LOX reactions substrates. The 
poor metabolism is due to the configuration of EPA, which misaligns the carbon 13 by 
COX-1 binding with respect to Tyr-385, the residue that abstracts hydrogen from 
substrate FA and leads to a 7-fold oxygenation reduction relative to AA.  Regardless, 
EPA and other C20 PUFA are in some extent metabolized by COX and 5-LOX 
producing eicosanoids of the 3-series of PGs and the 5-series of LT respectively. 
Moreover, most eicosanoids resulting from COX and LOX action on EPA are 
considered to be bioactive weaker than the AA metabolites. Consequently, EPA and 
other C20 PUFA competitively inhibit AA metabolism leading to a decreased capacity by 
immune cells of eicosanoids synthesis from AA. PUFA of the n-3 series also enhance 
the catabolism of eicosanoids by increasing the latter’s peroxisomal degradation. 
Dietary DHA inhibits PGE2 and LTB4 production both by itself and by retro conversion to 
EPA. The ALNA intake also decreases in a minor extent the PGE2 production. 30-31-32-33 
The impact of eicosanoids derived from n-6 and n-3 PUFA on inflammatory 
processes and particularly immune function is not easily predictable due to the parallel 
pro- and anti-inflammatory effects. 
Recently published data pointed out that DHA and EPA (or they derivatives) inhibit 
COX-2 receptor in monocytes. 32-33 
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Figure 3a. 
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Figure 3b.  
 
Eicosanoid Synthesis from PUFA of the n-6 (a) and n-3 Series (b).  
Metabolic pathways for the synthesis of prostaglandins, thromboxanes and leukotrienes 
are shown. For fatty acid names see table in the text. (Adapted from 32) 
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1.8 PUFA Effects on Gene Expression 
 
Fatty acids regulate gene function, either directly by interaction with nuclear 
receptors, or indirectly by altering signalling pathways initiated in the plasma membrane 
such as T-cell receptor (TCR) signalling. These signalling cascades regulate gene 
expression by altering activity transcription factors. Consequently, altered gene 
expression influences plasma membrane and cytoplasmic signalling by changing the 
cellular content and activity of involved proteins and their activators/repressors. Nuclear 
receptors are in a direct interaction with PUFA and their metabolites are reasonable 
candidates to mediate PUFA actions in the immune system.31-32 Nuclear receptors are 
transcription factors that are activated by ligand binding. So-called orphan nuclear 
receptors attach various lipophilic metabolites including fatty acids and their derivatives, 
thereby regulating the gene transcription. The γ-peroxisome proliferators-activated 
receptor (PPAR) interferes with lymphocyte activation and promotes the macrophages 
differentiation. While PPARα is activated by a large variety of fatty acids, PPARγ binds 
predominantly unsaturated fatty acids and some of their metabolites.31-32 The extent of 
the immunomodulatory action of the PPARs continue a matter of ongoing research. 32 
 
 
 
Figure 4.  Possible Mechanisms of Immune Cell Functional Modulation by PUFA.  
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1.9 Anti-Inflammatory Effects of Dietary Antioxidants  
 
Oxidative stress has been defined as a disturbance in the equilibrium status of pro-
oxidant/antioxidants systems in intact cells. It has been implicated in a wide range of 
human diseases such as cancer, eye injury, arthritis, rheumatic disorders, and 
particularly in a number of lung diseases, including asthma. Directly, important local 
antioxidants in the airways include ascorbic acid, α-tocopherol, zinc, glutathione, and 
proteins. Circulating antioxidant vitamins and other nutrients have been related to 
several components of the immune responses, and therefore, also linked to the 
development of atopic disease.13-14-15-16-17-18-19-20-34-35-36-37-38 
A complex interplay of activation and suppression mechanisms modulates the 
inflammatory processes. Commonly, when the antigen is rapidly disposed of, the 
inflammatory process is self-limited. By altered immuno-competence, the accumulation 
of macrophages and granulocytes lead to enhanced production of reactive oxygen 
species (ROS) and a number of mediators from the humoral and cellular sources 
specifically with cytokines  and the activity of COX 2 (s. above)30-34.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Oxidant Stress and Concomitant Inflammatory Processes34 
I-R: Ischemia-reperfusion, ROS: reactive oxygen species, IL: Interleikin, TNF: Tumor Necrosis Factor, PAF: Platelet Activating 
Factor, IF: Interferon, TGF: Transforming growth factor, CSF: Colony stimulating factor, MIF: Migration inhibitory factor, NFκB: 
Nuclear factor kappa B, PG: Prostaglandin, TX: Thromboxane, LT: Leukotriene 
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1.10 Biochemistry, Metabolism and Dietary Sources of Antioxidants and Zinc 
 
1.10.1 Vitamin A and Carotene 
 
Lipid soluble vitamin A and a group of more than 600 carotenoids have been 
characterized.  However, only 14 have been identified in human blood and tissue.39 The 
most prevalent carotenoids in the diet include α-carotene, β-carotene (the most active 
form), γ-carotene, lycopene, lutein, zeaxanthin, and  β-cryptoxanthin. But only few (α-
carotene, β-carotene, and β-cryptoxanthin) are converted to vitamin A and considered 
pro vitamin A carotenoids in foods.39, 40 
Functions of vitamin A include vision, cellular differentiation, morphogenesis, and 
other related physiological processes such as growth, reproduction, and immune 
response. The deficiency of vitamin A impairs the humoral response to infections, the 
cell-mediated immunity, the NK cell activity, phagocytosis, and nonetheless the activity 
of T lymphocytes. Vitamin A status is affected by intakes of protein, fat, iron, zinc and 
vitamin E, among others.29-30-38-39-40 
The only specific effect of carotenoids in humans is to act as a source of vitamin A in 
the diet however,  they also have important antioxidant actions. The latter are based on 
the carotenoids’ ability to quench singlet oxygen and trap peroxyl radicals, thereby 
preventing lipid peroxidation.39 As a result, carotenoids also protect against the 
development of cancer, CVD, and ocular disorders. In addition, carotenoids affect cell 
growth regulation and gene expression. Diets low in carotenoids may lead to an 
increased risk of cancer and heart disease. Carotenes also are associated with 
enhancing the immune function; however, as a pro vitamin to vitamin A, these results 
may be attributed to vitamin A, which is known to enhance immunity. Some research, 
however, does demonstrate immune-enhancing properties that can be attributed to the 
β-carotene molecule itself.39  
Good animal sources of preformed vitamin A are liver and other internal organs, 
eggs, dairy products, whole fish and fish oils. Primary vegetable sources of carotene 
include carrots, sweet potatoes, pumpkin, cantaloupe, pink grapefruit, spinach, apricots, 
broccoli, and most dark green leafy vegetables. (Table 2). 
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1.10.2 Vitamin C (Ascorbic Acid) 
 
The chemical name for Ascorbic Acid is 2, 3-didehydro-l-threohexano-1, 4-lactone; 
other terms included hexurionic acid, cevitamic acid, l-xylosascorbic acid, and vitamin 
C. Currently, vitamin C is used as the generic name for all compounds exhibiting 
qualitatively the biological activity of ascorbic acid. Ascorbic acid is considered an 
essential water-soluble vitamin in the diet based on the human lack of gulonolactone 
oxidase, which catalyzes the last step in its synthesis from glucose.29-30-40 
Ascorbic acid is easily oxidized to dehydroascorbic acid (DHAA), and further to 
inactive diketogulonic acid. Both, ascorbic acid and DHAA provide biological activity 
(antiscorbutic), contrary to their immediate oxidation product diketogulonic acid and 
isoascorbic acid. However, isoascorbic acid in biological tissues and fluids shows 
vitamin C-like activity acting as biological antioxidant.29-30-40 
Vitamin C constitutes the first defence line of the redox state in plasma, only when 
the ascorbate is depleted, other compounds become oxidized. Ascorbate modulates the 
redox chemistry of iron, and scavenges superoxide anions, hydroxyl radicals, peroxyl 
radicals, ozone, and nitric oxide.17-34-36-40 
Ascorbate acts together with vitamin E in lipid protection against oxidative stress by 
regenerating α-tocopherol from α-tocopheryl radicals in membranes and lipoproteins. 
Vitamin C is also involved in the collagen formation, carnitine biosynthesis, 
neurotransmitter synthesis, and iron absorption. 29-30-40 
The vast majority of vitamin C in western diets derives from fresh foods of vegetable 
origin, mainly citrus fruits, green vegetables, peppers, tomatoes, berries, and potatoes 
(Table 2). A reduced amount is delivered by fortified products, meat, fish, poultry, and 
eggs.29-30-40 
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1.10.3 Vitamin E 
 
Due to its lipid soluble nature, vitamin E concentrates in the interior of membranes 
lipoproteins and other molecules, having a crucial role as a major scavenger of free 
radicals in the lipid phase. Vitamin E is capable of protecting structural PUFA that are 
susceptible to peroxidation and prevents the propagation of lipid peroxidation.29-30-34-40 
Additionally, tocopherols quench and react with oxygen reactive species, preserve 
the NO reservoir, and are involved in the reduction of iron an copper. 
There are eight naturally occurring complexes with characteristics and biological 
activity attributable to vitamin E, divided in tocopherols and tocotrienols. The most 
abundant and active form among these eight isomers is α-tocopherol, but also present 
in foods are β-, γ-, and δ-tocopherols. Research suggests that the mixed forms found in 
food may be more beneficial than the isolated α -tocopherol form that is used in some 
supplements. 
Vitamin E is necessary for maintaining a healthy immune system, and it protects the 
thymus and circulating white blood cells from oxidative damage.36 Also, it may work 
synergistically with vitamin C in enhancing the immune function.17  
LDL is the main carrier of tocopherol in plasma. A lack of this vitamin increases the 
susceptibility of lipoproteins and membranes to peroxidation. Vitamin E exerts a wide 
variety of functions that might limit or delay the development and/or progression of 
inflammatory processes such as atheroesclerosis. It also enhances the bioactivity of 
nitric oxide, inhibits the COX-2, diminishes platelet aggregation, and reduces the 
production of inflammatory mediators in the macrophages among other functions. 
Recently, vitamin E has been linked to the inhibition of PLA2 and the subsequent 
regulation of AA metabolism via COX and LOX pathways.17, 34 
Dietary sources of vitamin E include vegetable oils such as corn, wheat germ and 
soybean oils, margarine, nuts, and grains. (Table 2).29-30-40 
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1.10.4 Zinc 
 
The dietary group IIb metal zinc (Zn) plays a crucial role in cellular metabolism 
and gene expression. It is a essential component of biomembranes, enzymes, and 
hormone receptors. It also stabilizes the nucleic acids structures and protects the 
integrity of sub cellular organelles. It regulates a large number of cellular processes 
including mitosis, apoptosis, secretion, and signal transduction as well as critical events 
in physiological processes as diverse as insulin release, T-cell cytokine production, 
wound healing, vision, and neurotransmission. Zn is present in all organs, tissues, 
fluids, and secretions of the body and is primarily an intracellular ion.29-30-34-40 
 Zinc is founded richly in the airways epithelium, its deficiency results in enhanced 
oxidative damage in the airways by causing infiltration of inflammatory cells and 
increased superoxide and nitric oxide production.15-17 
 Moreover, Zn deficiency results in a variety of immunologic defects. Severe 
deficiency is linked to thymic atrophy, lymphopenia, altered lymphocyte proliferation, 
and a decrease in NK cell and T4 activity. A lack of Zn shifts the Th1/Th2 balance 
towards Th2, thus giving rise to interleukin-4, LTB4 and PGE2 levels. 41 
Meat, fish, oysters, other shellfish, liver, whole grain cereals, dry beans, and nuts 
are the main dietary sources of zinc. Milk and milk products also contribute to deliver 
zinc in the diet.29-30-34-40 (Table 2). 
 
Table 2. Dietary Sources of Antioxidant Vitamins and Zinc. 
 
 
Vitamins Dietary Sources 
 
Vitamin A 
 
Liver, milk, cheese, egg yolk, fish oils. 
 
Carotene 
 
Apricot, cantaloupe melon, mango, carrot, kale, pepper, 
broccoli, spinach, sweet potato, squash. 
 
Vitamin C 
 
Citrus fruits and juices, kiwi, broccoli, green pepper, Brussels 
sprouts, strawberries, tomatoes, mango, papaya, potatoes. 
 
Vitamin E 
 
Wheat germ, grains, vegetable oils, margarine, mayonnaise, 
almonds, milk, peanuts, whole grain cereals, eggs. 
 
Zinc 
 
Shellfish, beef, red meats, whole grain cereals, nuts, legumes, 
fortified cereals. 
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2 Materials and Methods 
 
2.1 Study Design 
 
 This is a cross sectional study using data from the European Community 
Respiratory Health Survey (ECRHS) (www.erchs.org) and MONICA (MONItoring of 
Trends and Determinants in CArdiovascular Diseases) projects. The methods have 
been described in detail elsewhere and are summarised here briefly. 42-43-44  
 The ECRHS represented an enormous international effort to develop a 
standardised protocol to allow collecting feasible data on the geographical variation of 
the asthma and atopic disease prevalence and their treatment in a large number of 
European countries. Within the framework of the MONICA Study, Erfurt data about 
dietary habits was collected from the study subjects. One of the objectives of this 
international program conducted by the World Health Organisation was to assess the 
extent to which trends in coronary heart disease morbidity and mortality are related to 
cardiovascular risk factors, such as dietary habits.45 
 
2.2 Study Area 
 
 The city of Erfurt, in the former German Democratic Republic, with approximately  
210 000 inhabitants, was selected to participate in the ECRHS because this city met 
one of the established criteria: The city is a pre-existing administrative boundary with a 
population of at least 150 000. Furthermore, the adult Erfurt population served as one of 
the MONICA subpopulations.42 
 
2.3 Sources of Data 
 
 Data was collected between 1991 and 1992 from a cross sectional study that 
combined the European Community Respiratory Health Survey and the MONICA Study. 
Both studies offered high-quality data sampling to expedite the creation of a database, 
from where this analysis was derived. 
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2.4 Data Collection 
 
 The ECRHS survey was conducted in two stages. In stage I, subjects completed 
a mailed screening questionnaire that collected information about symptoms suggestive 
of asthma and atopic disease and their treatment (see attached questionnaire). Stage II 
consisted of a wider interviewer-led questionnaire with 71 items and a medical 
examination that consisted of determining the total and specific IgE as well as 
spirometry and a metacholine challenge test. Data on background factors 
(sociodemographic factors, living conditions, and parental atopy) were also gathered. At 
the same time, the MONICA survey including dietary assessment was carried out. 
Subjects were examined between September 1991 and June 1992. The study protocol 
obtained approval from the local ethics committee of the Medizinische Akademie 
Erfurt.43-44  
 
2.5 Study Population 
 
 Subjects eligible for the study were adults between the ages of 20 and 64, who 
were residents of the Thuringian city of Erfurt in Germany. The participants were 
selected randomly from the residential registry. A total of 1281 persons who attended 
the medical examination (Stage II) were invited to participate in the dietary survey. The 
final study population consisted of 469 men and 333 women who conducted acceptable 
dietary protocols and whose measurement of total and specific immunoglobulin E (IgE) 
were available (Figure 6).  
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Figure 6.  Study Population 
 
Total Random Sample
N = 2478
92.1%
Definite sample
N = 2297
55.8%
1281 ECRHS study 
participants
939 participants in food 
record keeping
83.6%
807 returned complete 
food record
99.4%
802 accepted food 
records
Men=469
Women=333
63.6%
7.9%
181 drop out
(death, move, etc.)
1016 refuser
44.2%
342 refused instruction 
meeting
36.4%
132 interrupted the study
16.4%
5 exclusions
0.6%
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2.6 Dietary Assessment Methodology  
 
 Data on dietary intake was obtained using prospective three-day records. 
Trained nurses instructed the participants in record keeping. Food recording was 
supported by a combination of accurate weighing with letter scales, portion size 
estimation with household measures, and a booklet of portion size pictures. Supplement 
intakes were included in the dietary records.The participants completed the food 
records at home and returned them to the study nurse, who checked it briefly. Food 
records were rejected if not covering exactly two weekdays and one Sunday or 
holiday.45-46-47 
 Individual daily food consumption, energy, total fat, fatty acids, and antioxidant 
nutrients (vitamins A, C, E, and Zinc) were calculated from dietary records using a 
program developed in the GSF National Research Centre for Environment and Health 
based on the BLS-German national nutrient data file (Bundeslebensmittelschlüssel 
II.2).47-48 Although some nutrient calculations were available from previous work, all 
calculations were repeated with the updated nutrient data file to obtain better quality and 
consistent information because this data file is constantly being expanded and 
corrected. For the first time, the current version of the BLS allowed the calculation not 
only of fat in the form of saturated (SFA), monounsaturated and polyunsaturated fatty 
acids but also of the specific fatty acids (arachidonic acid, for example). Therefore, the 
dietary data of this paper may not necessarily be identical to published data which was 
derived using the preceding BLS II.1. 
 Food intakes were presented as daily absolute amounts (g/day of consumed 
food). Fatty acids intake was computed as amount of the nutrient in grams pro 1000 
kcal/day, and antioxidants intake was presented as mg of the vitamin pro 1000 kcal/day. 
 
2.7 Outcome Definition 
 
 The following outcome variables from the ECRHS were separately considered: 
asthma, bronchial hyperresponsiveness, allergic sensitisation, reported hay fever, and 
atopic eczema. 
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 Asthma was defined as a positive answer to the question “Have you ever had 
asthma?” and whether diagnosis was confirmed by a physician. (See attached 
questionnaire) 
 The Methacholine inhalation challenge test was performed using a Mefar MB3 
dosimeter (Bovezzi, Italy) in all subjects with a forced expiratory volume greater than 
70% of the predicted mean and greater than an absolute value of 1.5 L, who were 
willing to participate. Bronchial hyperresponsiveness (BHR) was defined as 20% or 
greater fall in baseline forced expiratory volume in one second before a maximal 
cumulative dose of methacholine (2 mg) was administered.42-43 Allergic sensitisation was 
assessed by the measurement of specific IgE against common aeroallergens such as 
dermatophagoides pteronyssinus, timothy grass, cat allergen, cladosporium herbarum, 
and birch, using the Pharmacia CAP System (Uppsala, Sweden).10 The cut-off to define 
sensitisation was set on >0,7 kU/l (RAST Class>2) from at least one positive specific 
IgE.10-42-43 (Figure 7). 
Presence of current hay fever as well as life-time atopic eczema was derived 
from the questionnaire on the basis of a positive answer about those conditions.  
 
Cladosporium 
Herbarum
 Birch
Dermatophagoides 
pteronyssinus
   Timothy
   grass
Sensitisation defined as
at least one specific IgE
≥ 0.7 k U L
Cat allergen
 
 
Figure 7. Definition of Atopic Sensitisation 
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2.8 Statistical Approach 
 
 The patterns of absolute food and nutrient consumption were described using 
mean, median, standard deviations, and quartiles, all stratified by sex. The Wilcoxon-
Mann-Whitney Test was applied between the analysed strata. Pearson’s correlation 
coefficients analyses between consumed fatty acids were presented. 
 Prevalence of the outcome variables is given. Differences between gender and 
age groups were determined by X² test of homogeneity. Subjects were dichotomised 
according to the presence of allergic disease. Multiple logistic regression models were 
used to analyse the association between food, fatty acids, antioxidants intake, and 
atopic diseases. Odds ratios and their 95% confidence intervals were computed for the 
second, third, and highest intake quartiles compared to the first. Linear trends were 
calculated. Reported odds ratios were adjusted for age group, social class (defined by 
educational level), genetic predisposition (parental asthma or atopy), smoking habits, 
and body mass index. Data analysis was performed with the SAS Software Packet, 
version 8.1 (SAS Institute, Cary, NC, USA). 
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3 Results  
 
 Of the 1281 persons who attended the medical examination, 62.6% participated 
in the dietary survey. Acceptable records on food consumption were obtained from 802 
persons, 63% of whom were male (Figure 6). A Metacholine test for bronchial 
hyperreactivity was carried out in 613 study participants. 
 The prevalence of asthma, atopic sensitisation, hay fever, and atopic eczema did 
not differ between genders, but the bronchial hyperresponsiveness rate was higher in 
women (Table 3). The proportion of study participants aged between 40 and 64 years 
was higher in males. Differences were also observed for all educational levels in which 
the proportion of men was higher. There was also a higher proportion of male smokers 
(Table 3). 
 Based on its low prevalence in the study sample (less than 5 %), asthma was 
discharged as outcome variable for the subsequent statistical analysis (Table 3). 
 
Table 3. Description of the Study Population. Adults 20-64 Years from Erfurt. 
 
                                                                  
Total Men Women p-Value 
 n % n % n %  (X2 Test) 
Allergic Outcomes 
       
Asthma* 26 3.4 16 3.6 10 3.1 0.72 
Bronchial hyperresponsiveness ** 122 19.9 58 15.8 64 26.1 0.002 
Atopic sensitisation a 176 23.1 102 23.0 74 23.2 0.95 
Hay fever 83 10.9 44 9.9 39 12.2 0.32 
Atopic eczema 199 26.1 106 23.9 93 29.2 0.12 
Age groups 
  
 
    
20-40 369 48.4 196 44.2 173 54.2 0.23 
41-64 393 51.6 247 55.8 146 45.8 <0.001 
Social Class b 
       
  Less than 10 years 352 46.2 210 47.4 142 44.5 <0.001 
  10 years 238 31.2 134 30.3 104 32.6 0.05 
  More than 10 years 172 22.6 99 22.4 73 22.8 0.05 
Smoking Habits 
  
 
    
Smokers 251 32.9 161 36.3 90 28.2 <0.001 
Non-Smokers 511 67.1 282 63.7 229 71.8 0.02 
*Physician diagnosed asthma 
**n=613 
a
 Defined as at least one specific IgE concentration of >0,7 k U/l (RAST Class  >2) 
Bold fonts: indicate significance 
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3.1 Food consumption  
 
3.1.1 Fat Intake 
 
 The data on consumption of selected food items and nutrients for men and 
women indicate significantly higher absolute butter and margarine intakes in men than 
in women (Table 4). In men margarine intake was positively associated with the 
presence of hay fever but not with atopic sensitisation. Those associations were not 
found among women, in whom only high oil intake was positively related to atopic 
eczema prevalence (Table 6). The fish consumption in the analysed sample was too 
low to assess potential effects (data not shown).  
 
3.1.2 Vegetables 
 
 In men, high fresh vegetable consumption seems to be negatively linked to 
atopic sensitisation with a significant trend (p<0.01) among the intake categories, 
indicating a dose response relation. Correspondingly, a protective effect of moderate 
and normal vegetable products intake related to atopic sensitisation (odds ratio 0.40, CI 
0.18 to 0.88 and odds ratio 0.33, CI 0.16 to 0.72 respectively) was found in women. 
Conversely, prevalence of atopic eczema was directly related to high vegetable 
consumption in men (Odds ratio 3.05, CI 1.55 to 5.99).  
 
3.2 Fatty Acids 
 
 Fat consumption patterns showed no significant differences between women and 
men with the exception of alpha-linolenic, which was higher in women (Table 4). Table 5 
showed Pearson’s correlation coefficient between consumed fatty acids. 
 Statistical significance for associations between fat intake and health outcomes 
were mostly limited to women.  
In men there were no associations between fat intake and prevalence of atopic 
sensitisation.  
 In women, a high fat intake was positively related to atopic sensitisation (odds 
ratio 2.42, CI 1.07 to 5.50) and hay fever (Tables 8, 10). An increasing trend in the odds 
ratios for allergic sensitisation was observed with increased intake of saturated and 
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monounsaturated fats (Table 8). This association was also found for high intakes of 
specific monounsaturated fatty acids, such as palmitoleic and oleic acid (odds ratio 
3.04, CI 1.26 to 7.30 and odds ratio 2.47, CI 1.13 to 5.41 respectively). High intake of 
arachidonic acid, an n-6 polyunsaturated fatty acid with pro-inflammatory effects, was 
associated with allergic sensitisation (odds ratio 2.47, CI 1.13 to 5.41). Sensitisation 
prevalence decreased with higher polyunsaturated to saturated fatty acid ratios (odds 
ratio 0.39, CI 0.18 to 0.85, P 0.01). 
 In men, a high omega-6 to omega-3 ratio was positively related with hay fever 
(odds ratio 2.81, CI 1.10 to 7.16). Table 9 shows associations between fat consumption 
and hay fever. In women, significant odds ratios coincide with those reported above for 
atopic sensitisation. A high intake of total fat, monounsaturated fatty acids and oleic acid 
consumption were positively linked with hay fever.  
 Also found in women, a high consumption of the n-3 precursor, alpha-linolenic 
acid, was negatively associated with atopic eczema, whereas both the linoleic to alpha-
linolenic acid ratio and the total omega-6 to omega-3 ratio were significantly related to 
atopic eczema prevalence; however, the confidence intervals of the computed odds 
ratios included the value one (Table 10). 
 No significant association between fat intake and BHR in either the strata was 
found (Table 7). 
 
3.3 Antioxidants 
 
 No clear relationships between antioxidant nutrients consumption and allergic 
disease were observed. Statistically, women showed a significantly higher consumption 
of carotene, vitamin E and vitamin C pro 1000 kcal than men (p ≤0.0001 for all items) 
(Table 4). 
 Vitamin C and atopic eczema were positively associated in men (odds ratio 2.06, 
CI 1.05 to 4.06) (Table 14).  
 No effects were found for atopic disease outcomes and antioxidants nutrient 
intakes in women (Tables 11, 12, 13, 14). 
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Table 4. Daily Consumption of Selected Foods and Nutrients 
  
Men Women 
 
Mean SD 25th 
Perc. 
50th 
Perc. 
75th 
Perc. 
Mean SD 25th 
Perc. 
50th 
Perc. 
75th 
Perc. 
P value* 
Food intake (g/day) 
          
 
Butter 18 26 1 8 27 12 15 0.5 7 18 <0.001 
Margarine 29 23 10 24 41 22 18 9 17 31 <0.001 
Vegetable oils 3.6 6.0 0 1.2 4.6 3.2 4.7 0 1.6 4.5 0.30 
Fresh fruits 151 133 41 128 228 168 109 80 153 231 0.05 
Fresh vegetables 237 125 154 219 297 187 94 114 176 258 <0.001 
Vegetable products 21 34 0.0          5 27 24 33 0 8 38 0.2 
Fat intake (g/1000kcal/day) 
           
Total Fat 45 7 40 45 50 45 7 40 45 49 0.55 
SFA 18 4 15 17 20 18 4 15 18 21 0.25 
MUFA 17 3 15 17 19 17 3 15 17 19 0.10 
PUFA 6.9 2.4 5.1 6.5 8.1 7.1 2.5 5.3 6.8 8.6 0.11 
Palmitoleic acid~ 1.2 0.25 1.0 1.2 1.3 1.2 0.27 0.97 1.2 1.3 0.18 
Oleic acid~ 15 3 13 14 16 14 3 12 14 16 0.10 
Linoleic acid+ 5.9 2.3 4.3 5.4 7.1 6.1 2.4 4.4 5.7 7.5 0.20 
Alpha-Linolenic acid+ 0.72 0.28 0.60 0.70 0.80 0.78 0.31 0.65 0.73 0.86 <0.001 
Arachidonic acid+ 0.10 0.05 0.06 0.08 0.12 0.10 0.07 0.06 0.08 0.12 0.98 
Linoleic acid/Alpha-Linolenic 
acid+  
8.3 2.8 6.6 7.9 9.4 8.0 3.1 6.2 7.6 9.5 0.07 
P/S ratio  0.40 0.18 0.28 0.39 0.52 0.43 0.19 0.31 0.40 0.52 0.49 
Omega6/Omega3 ratio+ 7.6 2.6 5.9 7.3 8.7 7.4 2.7 5.6 6.9 8.6 0.08 
Antioxidants(mg/1000kcal/d
ay) 
           
Vitamin A 0.76 0.55 0.99 0.40 0.76 0.82 0.60 1.03 0.42 0.82 0.43 
Carotene 0.86 0.65 0.73 0.40 1.02 1.32 0.90 1.21 0.55 1.65 <0.0001 
Vitamin C 36.8 32.2 23.9 20.7 46.8 63.5 56.9 46.4 38.8 78.3 <0.0001 
Vitamin E 5.07 4.73 1.96 3.76 6.02 5.81 5.33 2.49 4.30 6.68 <0.0001 
Zinc 4.85 4.75 9.68 4.16 5.39 5.09 4.9 1.09 4.29 5.72 0.018 
 
* Wilcoxon-Mann-Whitney-Test. 
SD: standard deviation, Perc: percentile, SFA: saturated fatty acids, MUFA: monounsaturated fatty acids, 
PUFA: polyunsaturated fatty acids, P/S ratio: polyunsaturated/saturated ratio. 
~ monounsaturated fatty acid 
+ polyunsaturated fatty acid 
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Table 5. Pearson’s Correlation Coefficients Between Consumed Fatty Acids 
Stratified for Women and Men 
 
SFA: saturated fatty acids, MUFA: monounsaturated fatty acids, PUFA: polyunsaturated fatty acids, P/S 
ratio: polyunsaturated to saturated ratio. 
~ monounsaturated fatty acid 
+ polyunsaturated fatty acid 
Bold fonts: indicate significance 
 
 
 
 
 
 
 
Women Total fat SFA MUFA PUFA Palmito- leic acid Oleic  acid Linoleic  acid α- Linole- nicacid Arachido-nic acid Linoleic /  α- Linolenic 
acid 
PSQ Omega6/ 
Omega3 
Men 
Total fat 1.00 0.77 0.9 0.44 0.74 0.87 0.39 0.34 0.16 0.02 -0.03 0.04 Total fat 
  
<.0001 <.0001 <.0001 <.0001 <.0001 <.0001 <.0001 0.000 0.66 0.56 0.52  
             
SFA 0.74 
 
1.00 0.56 -0.15 0.55 0.56 -0.18 0.12 0.08 -0.36 -0.57 -0.34 SFA 
 
<.0001  <.0001 0.01 <.0001 <.0001 0 0.03 0.13 <.0001 <.0001 <.0001  
              
MUFA 0.86 0.45 1.00 0.36 0.83 0.95 0.32 0.25 0.18 0.01 -0.02 0.02 MUFA 
 
<.0001 <.0001  <.0001 <.0001 <.0001 <.0001 <.0001 0 0.92 0.67 0.66  
              
PUFA 0.46 -0.14 0.4 1.00 0.13 0.35 0.98 0.44 0.09 0.65 0.84 0.63 PUFA 
 
<.0001 0 <.0001 
 
0.02 <.0001 <.0001 <.0001 0.12 <.0001 <.0001 <.0001  
              
~
Palmitoleic acid 0.68 0.45 0.8 0.1 1.00 0.71 0.07 0.15 0.3 -0.16 -0.18 -0.2 Palmitoleic acid 
 
<.0001 <.0001 <.0001 0.03 
 
<.0001 0.19 0.01 <.0001 0 0 0  
              
~
Oleic acid 0.85 0.46 0.96 0.38 0.69 1.00 0.33 0.23 0.14 0.05 -0.02 0.09 Oleic acid 
 
<.0001 <.0001 <.0001 <.0001 <.0001 
 
<.0001 <.0001 0.01 0.4 0.66 0.11  
              
+
Linoleic acid 0.43 -0.15 0.37 0.98 0.05 0.38 1.00 0.34 0.03 0.73 0.85 0.73 Linoleic acid 
 
<.0001 0 <.0001 <.0001 0.33 <.0001  <.0001 0.6 <.0001 <.0001 <.0001  
              
+
α -Linolenic 
acid 
0.43 0.16 0.34 0.49 0.27 0.3 0.38 -0.01 -0.23 0.26 -0.21 α -Linolenic acid 
 
<.0001 0 <.0001 <.0001 <.0001 <.0001 <.0001 
1.00 
0.85 <.0001 <.0001 0  
              
+
Arachidonic 
acid 
0.07 -0.03 0.09 0.1 0.22 0.08 0.05 1.00 0.05 0.01 -0.01 Arachidonic acid 
 0.14 0.59 0.07 0.03 <.0001 0.08 0.27 
-0.02 
0.61 
 0.33 0.82 0.86  
             
0.06 -0.36 0.08 0.67 -0.2 0.12 0.74 -0.12 0.11 1.00 0.72 0.95 +Linoleic acid/ 
α- Linolenic acid 
0.23 <.0001 0.11 <.0001 <.0001 0.01 <.0001 0.01 0.03  <.0001 <.0001 
Linoleic acid/ 
α- Linolenic acid 
  
 
           
 -0.01 -0.56 0.05 0.84 -0.16 0.03 0.82 0.33 0.09 0.69 1.00 0.68  
P/S ratio 0.89 <.0001 0.33 <.0001 0 0.6 <.0001 <.0001 0.07 <.0001  <.0001 P/S ratio 
              
+
Omega6/ 0.09 -0.3 0.12 0.63 -0.21 0.18 0.72 -0.1 0.01 0.94 0.61 1.00 Omega6/ 
                 
Omega3 
0.05 <.0001 0.01 <.0001 <.0001 0 <.0001 0.04 0.79 <.0001 <.0001   Omega3 
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Table 6 a. Associations Between Selected Food Consumption and BHR a,  Allergic 
Sensitisation b, Hay Fever, and Atopic Eczema in Men 
 
          Men                                                                     Adjusted OR* (95% CI) 
Intake c 
g/day 
 1st 
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for 
Trend 
Butter        BHR a 1.00 0.84(0.36-1.97) 0.79(0.35-1.80) 0.99(0.44-2.18) 0.69 
                  
Sensitisation b 1.00 0.73(0.38-1.41) 1.06(0.57-1.96) 0.93(0.50-1.75) 0.70 
                                    Hay fever 1.00 0.79(0.35-1.75) 0.41(0.16-1.05) 0.47(0.19-1.18) 0.09 
 Atopic eczema 1.00 1.63(0.87-3.06) 1.25(0.66-2.37) 0.93(0.48-1.82) 0.41 
Margarine                  BHR a 1.00 1.82(0.82-4.04) 1.28(0.54-3.04) 0.97(0.41-2.30) 0.40 
 
Sensitisation b 1.00 0.59(0.31-1.11) 0.62(0.33-1.17) 0.74(0.40-1.38) 0.09 
 Hay fever 1.00 3.23(1.01-10.35) 3.25(1.02-10.39) 3.04(0.95-9.73) 0.03 
                                 Atopic eczema 1.00 2.01(1.07-3.79) 1.53(0.79-2.99) 1.00(0.50-1.98) 0.15 
Vegetable oils           BHRa 1.00 1.33(0.53-3.35) 1.08(0.51-2.30) 1.13(0.53-2.41) 0.65 
 
Sensitisation b 1.00 0.54(0.25-1.17) 0.65(0.36-1.15) 0.65(0.36-1.16) 0.04 
 Hay fever 1.00 1.59(0.58-4.34) 1.34(0.56-3.17) 1.82(0.80-4.14) 0.20 
 Atopic eczema 1.00 0.40(0.17-0.92) 0.61(0.34-1.10) 0.96(0.56-1.67) 0.11 
Fresh fruits              BHRa 1.00 1.38(0.61-3.13) 1.32(0.58-2.98) 0.86(0.36-2.05) 0.64 
 
Sensitisation a 1.00 1.24(0.67-2.29) 0.66(0.34-1.30) 1.03(0.54-1.95) 0.87 
 Hay fever 1.00 1.20(0.48-2.96) 0.92(0.36-2.33) 1.10(0.44-2.73) 0.87 
 Atopic eczema 1.00 1.12(0.59-2.13) 1.44(0.77-2.70) 0.80(0.40-1.58) 0.69 
Fresh Vegetables BHRa 1.00 0.78(0.34-1.81) 1.07(0.49-3.33) 0.89(0.40-2.00) 0.21 
 Sensitisation a 1.00 0.47(0.25-0.90) 0.60(0.33-1.10) 0.48(0.25-0.91) 0.009 
 Hay fever 1.00 0.90(0.37-2.17) 0.76(0.30-1.93) 0.96(0.40-2.30) 0.72 
 Atopic eczema 1.00 1.72(0.86-3.45) 1.69(0.84-3.41) 3.05(1.55-5.99) 0.01 
Vegetable products        BHRa 1.00 0.76(0.35-1.66) 0.36(0.14-0.90) 0.98(0.47-2.06) 0.21 
 Sensitisation a 1.00 1.23(0.64-2.35) 1.28(0.71-2.32) 0.83(0.44-1.57) 0.73 
 Hay fever 1.00 2.11(0.85-5.24) 1.52(0.62-3.69) 1.12(0.44-2.83) 0.28 
 Atopic eczema 1.00 1.48(0.78-2.80) 0.77(0.40-1.46) 1.42(0.79-2.58) 0.54 
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Table 6 b. Associations Between Selected Food Consumption and BHR a,  Allergic 
Sensitisation b, Hay Fever, and Atopic Eczema in Women. 
 
          Women                                                               Adjusted OR* (95% CI) 
Intake c 
g/day 
 1st 
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for 
Trend  
Butter        BHR a 1.00 1.27(0.55-2.93) 1.07(0.45-2.53) 1.15(0.49-2.68) 0.68 
               
Sensitisation b 1.00 1.08(0.51-2.27) 0.52(0.23-1.17) 1.16(0.55-2.45) 0.70 
                                    Hay fever 1.00 0.92(0.34-2.46) 0.55(0.20-1.53) 0.94(0.36-2.46) 0.54 
                                   Atopic eczema 1.00 1.43(0.70-2.89) 1.46(0.73-2.93) 0.99(0.48-2.06) 0.40 
Margarine      BHRa 1.00 0.78(0.35-1.76) 0.77(0.34-1.73) 0.48(0.20-1.18) 0.27 
            
Sensitisation b 1.00 1.00(0.47-2.13) 0.96(0.45-2.04) 0.75(0.34-1.66) 0.75 
                                    Hay fever 1.00 1.36(0.49-3.78) 1.66(0.62-4.40) 1.25(0.42-3.68) 0.41 
                                     Atopic eczema 1.00 0.79(0.39-1.58) 1.33(0.68-2.57) 0.53(0.25-1.12) 0.60 
Vegetable oils           BHRa 1.00 0.93(0.36-2.41) 1.31(0.61-2.82) 1.18(0.55-2.55) 0.62 
 
Sensitisation b 1.00 1.07(0.50-2.32) 0.55(0.26-1.17) 0.63(0.30-1.31) 0.20 
                                   Hay fever 1.00 0.97(0.30-3.12) 1.41(0.56-3.54) 1.59(0.62-4.09) 0.43 
                                   Atopic eczema 1.00 2.12(1.00-4.46) 1.45(0.73-2.88) 2.09(1.06-4.10) 0.04 
Fresh fruits              BHRa 1.00 1.23(0.62-2.44) 0.95(0.32-2.82) 0.99(0.75-1.31) 0.48 
 
Sensitisation a 1.00 0.99(0.47-2.07) 0.95(0.45-2.00) 0.67(0.30-1.51) 0.67 
                                   Hay fever 1.00 1.02(0.37-2.80) 1.24(0.47-3.26) 0.67(0.22-2.02) 0.98 
                                   Atopic eczema 1.00 0.90(0.45-1.79) 0.44(0.21-0.93) 0.89(0.44-1.78) 0.26 
Fresh vegetables        BHRa 1.00 0.79(0.34-1.81) 1.06(0.48-2.33) 0.86(0.38-1.93) 0.75 
 Sensitisation a 1.00 0.51(0.24-1.11) 0.66(0.31-1.40) 0.80(0.38-1.67) 0.15 
                                     Hay fever 1.00 0.41(0.14-1.20) 0.59(0.23-1.54) 0.65(0.25-1.68) 0.13 
                                     Atopic eczema 1.00 0.86(0.43-1.72) 0.98(0.49-1.95) 0.67(0.33-1.38) 0.53 
Vegetable products BHRa 1.00 1.21(0.48-3.09) 2.20(1.01-4.84) 1.88(0.86-4.10) 0.08 
 Sensitisation a 1.00 0.40(0.18-0.88) 0.33(0.16-0.72) 0.58(0.28-1.20) 0.004 
 Hay fever 1.00 1.35(0.51-3.59) 0.91(0.33-2.55) 1.27(0.49-3.31) 0.70 
 Atopic eczema 1.00 0.60(0.28-1.27) 1.15(0.59-2.23) 1.14(0.59-2.22) 0.87 
 
a BHR: bronchial hyperresponsiveness. Defined as 20% drop in FEV1 during methacholine provocation 
test. n=613 (Men=368, Women=245) 
b
 Defined as at least one specific IgE concentration of >0.7k U/l (RAST Class >2) 
c Intake was categorised according to food quartile of daily consumption 
*Adjusted for age group, educational level, history of parental atopy, smoking habits and body mass index 
OR: Odds ratio, CI: confidence intervals. 
Bold fonts: indicate significance 
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Table 7. Associations Between Dietary Intake of Fatty Acids and Bronchial 
Hyperresponsivenessa   in Adults 
 
                     Men                                                      Adjusted OR with 95% CI 
Intake c 
g/1000Kcal/day 
1st 
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for  
Trend 
Total fat 1.00 0.90 (0.41-1.99) 0.88 (0.41-1.92) 0.37 (0.14-0.93) 0.05 
SFA 1.00 0.87 (0.39-1.95) 0.87 (0.38-1.96) 0.62 (0.26-1.47) 0.31 
MUFA 1.00 0.35 (0.14-0.85) 0.90 (0.43-1.90) 0.35 (0.15-0.83) 0.11 
PUFA 1.00 0.65 (0.28-1.50) 1.26 (0.59-2.66) 0.57 (0.24-1.34) 0.49 
Palmitoleic acid~ 1.00 0.68 (0.30-1.50) 0.50 (0.22-1.13) 0.45 (0.20-1.02) 0.04 
Oleic acid~ 1.00 0.62 (0.27-1.44) 1.10 (0.52-2.35) 0.37 (0.15-0.90) 0.11 
Linoleic acid+ 1.00 0.90 (0.40-2.00) 1.32 (0.61-2.86) 0.54 (0.22-1.31) 0.36 
Alpha-Linolenic acid+ 1.00 0.67 (0.30-1.53) 0.82 (0.37-1.78) 0.57 (0.25-1.29) 0.24 
Arachidonic acid+ 1.00 1.04 (0.44-2.48) 1.13 (0.48-2.67) 1.34 (0.59-3.05) 0.46 
Linoleic acid/Alpha-Linolenic+ 1.00 1.26 (0.55-2.87) 1.26 (0.57-2.79) 0.92 (0.39-2.13) 0.84 
P/S ratio 1.00 1.04 (0.44-2.44) 1.69 (0.75-3.81) 1.12 (0.48-2.59) 0.55 
Omega6/Omega3 + 1.00 1.43 (0.62-3.27) 1.68 (0.75-3.80) 0.94 (0.39-2.26) 0.94 
 
                     Women                                                      Adjusted OR* with 95% CI 
Intake c 
g/1000Kcal/day 
1st 
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for  
Trend 
Total fat 1.00 0.56 (0.24-1.28) 0.54 (0.23-1.29) 0.89 (0.41-1.97) 0.81 
SFA 1.00 0.57 (0.24-1.33) 0.72 (0.32-1.63) 0.70 (0.31-1.59) 0.52 
MUFA 1.00 0.74 (0.32-1.69) 0.49 (0.21-1.13) 0.73 (0.33-1.61) 0.30 
PUFA 1.00 1.20 (0.54-2.66) 0.74 (0.32-1.72) 0.74 (0.32-1.75) 0.32 
Palmitoleic acid~ 1.00 0.64 (0.28-1.42) 0.37 (0.16-0.89) 0.72 (0.32-1.64) 0.26 
Oleic acid~ 1.00 0.55 (0.24-1.28) 0.63 (0.28-1.43) 0.62 (0.28-1.40) 0.31 
Linoleic acid+ 1.00 1.68 (0.75-3.75) 1.03 (0.44-2.40) 0.73 (0.30-1.76) 0.30 
Alpha-Linolenic acid+ 1.00 0.80 (0.34-1.87) 0.88 (0.39-1.96) 1.00 (0.44-2.29) 0.97 
Arachidonic acid+ 1.00 1.34 (0.60-3.02) 0.68 (0.28-1.62) 1.12 (0.48-2.60) 0.81 
Linoleic acid/Alpha-Linolenic+ 1.00 1.62 (0.73-3.60) 0.55 (0.23-1.36) 0.94 (0.41-2.15) 0.48 
P/S ratio 1.00 1.37 (0.63-2.99) 0.88 (0.38-2.06) 0.54 (0.23-1.29) 0.11 
Omega6/Omega3+  1.00 1.87 (0.83-4.22) 0.51 (0.21-1.27) 0.95 (0.41-2.16) 0.33 
c Intake was categorised according to food quartile of daily consumption  
a BHR: bronchial hyperresponsiveness. Defined as 20% drop in FEV1 during methacholine provocation 
test 
*Adjusted for age, educational level, history of parental atopy, smoking habits, and  body mass index 
OR: Odds ratio, CI: confidence intervals, SFA: saturated fatty acids, MUFA: monounsaturated fatty acids, 
PUFA: polyunsaturated fatty acids, P/S ratio: polyunsaturated to saturated ratio. 
~ monounsaturated fatty acid 
+ polyunsaturated fatty acid 
Bold fonts: indicate significance 
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Table 8. Associations Between Dietary Intake of Fatty Acids and Allergic 
Sensitisation in Adults 
 
                     Men                                                              Adjusted OR with 95% CI 
Intake c 
g/1000Kcal/day 
1st 
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for 
Trend 
Total fat 1.00 0.65(0.35 to 1.20) 0.57(0.30 to 1.07) 0.71(0.39 to 1.31) 0.23 
SFA 1.00 0.82(0.44 to 1.54) 1.11(0.61 to 2.02) 0.60(0.31 to 1.15) 0.26 
MUFA 1.00 0.61(0.32 to 1.14) 0.70(0.38 to 1.30) 0.72(0.39 to 1.33) 0.38 
PUFA 1.00 0.98(0.54 to 1.78) 0.69(0.37 to 1.29) 0.61(0.32 to 1.16) 0.08 
Palmitoleic acid~ 1.00 0.82(0.43 to 1.56) 0.91(0.48 to 1.73) 1.07(0.57 to 2.01) 0.78 
Oleic acid~ 1.00 0.75(0.40 to 1.39) 0.73(0.39 to 1.37) 0.65(0.35 to 1.23) 0.20 
Linoleic acid+ 1.00 0.99(0.55 to 1.81) 0.58(0.30 to 1.11) 0.67(0.36 to 1.27) 0.09 
Alpha-Linolenic acid+ 1.00 0.64(0.34 to 1.19) 0.52(0.27 to 0.99) 0.79(0.43 to 1.44) 0.35 
Arachidonic acid+ 1.00 1.21(0.66 to 2.23) 0.80(0.42 to 1.53) 0.65(0.33 to 1.26) 0.11 
Linoleic acid/Alpha-Linolenic+ 1.00 1.00(0.54 to 1.85) 0.65(0.34 to 1.26) 0.88(0.47 to 1.63) 0.46 
P/S ratio 1.00 0.86(0.46 to 1.61) 1.04(0.56 to 1.93) 0.72(0.37 to 1.38) 0.46 
Omega6/Omega3 + 1.00 0.78(0.42 to 1.46) 0.57(0.30 to 1.10) 0.86(0.46 to 1.59) 0.45 
 
              Women                                                       Adjusted OR with 95% CI 
Intake c 
g/1000Kcal/day 
1st 
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for  
Trend 
Total fat 1.00 2.52 (1.12-5.68) 1.56 (0.66-3.64) 2.42 (1.07-5.50) 0.12 
SFA 1.00 1.18 (0.51-2.76) 2.35 (1.07-5.17) 1,99 (0.89-4.46) 0.03 
MUFA 1.00 0.84 (0.36-1.99) 1.81 (0.83-3.94) 2.13 (0.98-4.62) 0.02 
PUFA 1.00 1.12 (0.54-2.34) 0.86 (0.40-1.85) 0.69 (0.32-1.51) 0.28 
Palmitoleic acid~ 1.00 3.01 (1.29-7.02) 2.86 (1.19-6.85) 3.04 (1.26-7.30) 0.02 
Oleic acid~ 1.00 1.44 (0.63-3.30) 1.52 (0.68-3.43) 2.47 (1.13-5.41) 0.03 
Linoleic acid+ 1.00 1.42 (0.67-3.02) 1.45 (0.68-3.08) 0.70 (0.31-1.60) 0.47 
Alpha-Linolenic acid+ 1.00 0.65 (0.30-1.43) 1.12 (0.53-2.36) 0.94 (0.45-1.98) 0.81 
Arachidonic acid+ 1.00 2.59 (1.16-5.77) 1.97 (0.85-4.58) 2.47 (1.07-5.72) 0.08 
Linoleic acid/Alpha-Linolenic+ 1.00 1.09 (0.52-2.24) 0.92 (0.44-1.93) 0.52 (0.23-1.17) 0.12 
P/S ratio 1.00 0.70 (0.34-1.44) 0.51 (0.24-1.09) 0.39 (0.18-0.85) 0.01 
Omega6/Omega3 + 1.00 0.80 (0.37-1.72) 1.22 (0.59-2.53) 0.57 (0.26-1.28) 0.36 
c
 Intake was categorised according to nutrient quartile of daily consumption 
a
 Defined as at least one specific IgE concentration of >0.7  k U/l (RAST Class>2) 
*Adjusted for age, educational level, history of parental atopy, smoking habits, and body mass index 
OR: Odds ratio, CI: confidence intervals, SFA: saturated fatty acids, MUFA: monounsaturated fatty acids, 
PUFA: polyunsaturated fatty acids. 
~ monounsaturated fatty acid 
+ polyunsaturated fatty acid 
Bold fonts: indicate significance 
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Table 9. Associations Between Dietary Intake of Fatty Acids and Hay Fever in 
Adults 
 
                     Men                                                 Adjusted OR* with 95% CI 
Intake c 
g/1000Kcal/day 
1st 
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for 
Trend 
Total fat 1.00 0.80(0.33 to 1.94) 0.72(0.29 to 1.79) 1.09(0.47 to 2.50) 0.89 
SFA 1.00 0.74(0.31 to 1.78) 0.81(0.35 to 1.90) 0.74(0.31 to 1.76) 0.54 
MUFA 1.00 0.82(0.34 to 1.98) 0.79(0.33 to 1.93) 0.98(0.42 to 2.29) 0.95 
PUFA 1.00 2.13(0.77 to 5.91) 2.70(1.01 to 7.25) 1.94(0.69 to 5.46) 0.20 
Palmitoleic acid~ 1.00 1.09(0.45 to 2.61) 0.66(0.25 to 1.73) 1.12(0.47 to 2.68) 0.97 
Oleic acid~ 1.00 1.16(0.48 to 2.79) 0.90(0.37 to 2.19) 0.88(0.35 to 2.20) 0.66 
Linoleic acid+ 1.00 2.10(0.75 to 5.88) 2.33(0.85 to 6.36) 2.14(0.76 to 5.98) 0.17 
Alpha-Linolenic acid+ 1.00 0.56(0.22 to 1.39) 0.52(0.20 to 1.33) 0.97(0.43 to 2.21) 0.96 
Arachidonic acid+ 1.00 0.52(0.22 to 1.24) 0.58(0.24 to 1.37) 0.55(0.23 to 1.32) 0.19 
Linoleic acid/Alpha-Linolenic+ 1.00 1.73(0.63 to 4.70) 1.56(0.58 to 4.23) 2.45(0.95 to 6.34) 0.09 
P/S ratio 1.00 1.51(0.55 to 4.10) 1.98(0.75 to 5.23) 2.01(0.76 to 5.32) 0.13 
Omega6/Omega3 + 1.00 1.55(0.56 to 4.31) 1.40(0.51 to 3.86) 2.81(1.10 to 7.16) 0.04 
 
                    Women                                                 Adjusted OR* with 95% CI 
Intake c 
g/1000Kcal/day 
1st 
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for  
Trend 
Total fat 1.00 3.14 (0.95 to 10.35) 1.28 (0.34 to 4.81) 4.51 (1.38 to 14.75) 0.05 
SFA 1.00 2.83(0.84 to 9.53) 1.93(0.55 to 6.75) 3.13(0.95 to 10.28) 0.13 
MUFA 1.00 0.94(0.29 to 3.03) 1.62(0.54 to 4.90) 3.04(1.07 to 8.59) 0.01 
PUFA 1.00 0.90(0.33 to 2.48) 1.10(0.40 to 3.03) 1.58(0.60 to 4.14) 0.31 
Palmitoleic acid~ 1.00 1.31(0.43 to 3.93) 1.57(0.52 to 4.71) 2.75(0.94 to 8.00) 0.06 
Oleic acid~ 1.00 2.60(0.76 to 8.84) 2.36(0.67 to 8.28) 4.99(1.53 to 16.32) 0.01 
Linoleic acid+ 1.00 1.08(0.38 to 3.08) 1.54(0.55 to 4.30) 1.97(0.73 to 5.35) 0.14 
Alpha-Linolenic acid+ 1.00 0.84(0.27 to 2.63) 1.93(0.70 to 5.33) 1.53(0.53 to 4.40) 0.21 
Arachidonic acid+ 1.00 0.99(0.37 to 2.60) 0.94(0.34 to 2.62) 1.22(0.46 to 3.21) 0.72 
Linoleic acid/Alpha-Linolenic acid+ 1.00 1.42(0.53 to 3.82) 1.39(0.50 to 3.83) 1.37(0.49 to 3.83) 0.58 
P/S ratio 1.00 1.07(0.42 to 2.74) 0.58(0.19 to 1.72) 1.16(0.45 to 2.94) 0.97 
Omega6/Omega3+ 1.00 1.79(0.62 to 5.12) 1.53(0.51 to 4.58) 2.38(0.83 to 6.81) 0.15 
c
 Intake was categorised according to nutrient quartile of daily consumption 
*Adjusted for age group, educational level, history of parental atopy, smoking habits, and body mass 
index 
OR: Odds ratio, CI: confidence intervals, SFA: saturated fatty acids, MUFA: monounsaturated fatty acids, 
PUFA: polyunsaturated fatty acids, P/S ratio: polyunsaturated to saturated ratio. 
~ monounsaturated fatty acid 
+ polyunsaturated fatty acid 
Bold fonts: indicate significance 
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Table 10. Associations Between Dietary Intake of Fatty Acids and Atopic Eczema  
in Adults 
 
                    Men                                                          Adjusted OR with 95% CI 
Intake c 
g/1000Kcal/day 
1st 
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for  
Trend 
Total fat 1.00 1.44(0.79 to 2.63) 1.16(0.63 to 2.16) 0.75(0.39 to 1.44) 0.31 
SFA 1.00 0.76(0.41 to 1.38) 0.82(0.45 to 1.49) 0.54(0.28 to 1.01) 0.08 
MUFA 1.00 0.78(0.42 to 1.43) 1.08(0.60 to 1.94) 0.56(0.29 to 1.06) 0.19 
PUFA 1.00 1.10(0.58 to 2.09) 1.40(0.75 to 2.61) 1.30(0.69 to 2.43) 0.32 
Palmitoleic acid~ 1.00 1.48(0.80 to 2.74) 1.28(0.68 to 2.40) 0.81(0.41 to 1.59) 0.50 
Oleic acid~ 1.00 0.90(0.49 to 1.68) 1.24(0.68 to 2.27) 0.46(0.23 to 0.92) 0.10 
Linoleic acid+ 1.00 0.94(0.49 to 1.82) 1.71(0.92 to 3.19) 1.07(0.56 to 2.06) 0.42 
Alpha-Linolenic acid+ 1.00 1.20(0.64 to 2.25) 1.10(0.58 to 2.06) 0.90(0.47 to 1.73) 0.71 
Arachidonic acid+ 1.00 0.77(0.41 to 1.47) 0.76(0.39 to 1.48) 1.57(0.85 to 2.89) 0.15 
Linoleic acid/Alpha-Linolenic+ 1.00 1.29(0.67 to 2.49) 1.69(0.89 to 3.21) 1.35(0.70 to 2.59) 0.32 
P/S ratio 1.00 1.56(0.81 to 3.01) 1.44(0.74 to 2.81) 1.77(0.93 to 3.38) 0.12 
Omega6/Omega3 + 1.00 1.45(0.75 to 2.80) 1.58(0.82 to 3.04) 1.49(0.78 to 2.85) 0.23 
 
                 Women                                                       Adjusted OR* with 95% CI 
Intake c 
g/1000Kcal/day 
1st 
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for  
Trend 
Total fat 1.00 1.18(0.59 to 2.35) 1.01 (0.50 to 2.03) 0.98(0.49 to 1.98) 0.85 
SFA 1.00 1.04(0.50 to 2.14) 1.62(0.81 to 3.24) 1.08(0.53 to 2.21) 0.55 
MUFA 1.00 1.12(0.56 to 2.24) 0.88(0.43 to 1.80) 1.19(0.60 to 2.38) 0.79 
PUFA 1.00 0.88(0.44 to 1.74) 0.84(0.42 to 1.69) 0.82(0.41 to 1.64) 0.57 
Palmitoleic acid~ 1.00 1.12(0.55 to 2.30) 1.75(0.87 to 3.50) 1.07(0.52 to 2.21) 0.57 
Oleic acid~ 1.00 0.81(0.40 to 1.64) 0.94(0.47 to 1.88) 1.04(0.52 to 2.08) 0.82 
Linoleic acid+ 1.00 1.16(0.59 to 2.30) 0.75(0.36 to 1.53) 1.02(0.51 to 2.04) 0.75 
Alpha-Linolenic acid+ 1.00 0.98(0.50 to 1.91) 0.77(0.38 to 1.54) 0.47(0.22 to 0.98) 0.04 
Arachidonic acid+ 1.00 2.01(1.01 to 4.02) 1.10(0.53 to 2.28) 1.19(0.57 to 2.47) 0.91 
Linoleic acid/Alpha-Linolenic+ 1.00 1.09(0.52 to 2.29) 1.79(0.88 to 3.65) 1.95(0.96 to 3.98) 0.03 
P/S ratio 1.00 1.57(0.78 to 3.19) 2.19(1.08 to 4.45) 0.80(0.37 to 1.72) 0.82 
Omega6/Omega3 + 1.00 1.36(0.65 to 2.85) 1.74(0.84 to 3.59) 2.02(0.98 to 4.15) 0.04 
c
 Intake was categorised according to nutrient quartile of daily consumption 
*Adjusted for age group, educational level, history of parental atopy, smoking habits, and body mass 
index 
OR: Odds ratio, CI: confidence intervals, SFA: saturated fatty acids, MUFA: monounsaturated fatty acids, 
PUFA: polyunsaturated fatty acids, P/S ratio: polyunsaturated to saturated ratio. 
~ monounsaturated fatty acid 
+ polyunsaturated fatty acid 
Bold fonts: indicate significance 
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Table 11. Associations Between Dietary Intake of Antioxidants and Bronchial 
Hyperresponsivenessa in Adults 
 
                     Men                                                      Adjusted OR with 95% CI 
Intake c 
Mg/1000Kcal/day 
1st  
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for  
Trend 
Vitamin A 1.00 1.06 (0.44-2.54) 1.18 (0.51-2.76) 1.82 (0.82-4.06) 0.41 
Carotene 1.00 0.99 (0.45-2.19) 0.84 (0.37-1.92) 0.94 (0.42-2.11) 0.82 
Vitamin E 1.00 0.97 (0.44-2.11) 0.94 (0.42-2.09) 0.80 (0.35-1.85) 0.76 
Vitamin C 1.00 0.38 (0.16-0.92) 0.69 (0.32-1.48) 0.76 (0.35-1.63) 0.11 
Zinc 1.00 0.73 (0.35-1.55) 0.62 (0.29-1.35) 0.29 (0.11-0.73) 0.05 
 
                     Women                                                 Adjusted OR* with 95% CI 
Intake c 
Mg/1000Kcal/day 
1st 
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for  
Trend 
Vitamin A 1.00 0.66 (0.29-1.53) 0.77 (0.33-1.78) 1.36 (0.61-3.04) 0.73 
Carotene 1.00 2.02 (0.89-4.57) 1.09 (0.43-2.74) 1.99 (0.86-4.59) 0.14 
Vitamin E 1.00 1.07 (0.49-2.37) 0.94 (0.40-2.17) 1.23 (0.54-2.79) 0.84 
Vitamin C 1.00 0.98 (0.42-2.30) 1.71 (0.77-3.77) 0.88 (0.36-2.11) 0.64 
Zinc 1.00 1.43 (0.63-3.26) 1.30 (0.57-2.96) 1.10 (0.45-2.68) 0.48 
 
c Intake was categorised according to food quartile of daily consumption  
a BHR: bronchial hyperresponsiveness. Defined as 20% drop in FEV1 during methacholine provocation 
test. 
*Adjusted for age, educational level, history of parental atopy, smoking habits, and body mass index 
OR: Odds ratio, CI: confidence intervals 
Bold fonts: indicate significance 
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Table 12. Associations Between Dietary Intake Antioxidants and Allergic 
Sensitisation in Adults 
 
                     Men                                                      Adjusted OR with 95% CI 
Intake c 
Mg/1000Kcal/day 
1st  
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for  
Trend 
Vitamin A 1.00 1.98 (1.03-3.79) 1.67 (0.86-3.25) 1.43 (0.73-2.82) 0.07 
Carotene 1.00 0.84 (0.45-1.56) 0.87 (0.47-1.64) 0.77 (0.41-1.45) 0.46 
Vitamin E 1.00 0.86 (0.47-1.59) 0.81 (0.43-1.50) 0.67 (0.35-1.27) 0.32 
Vitamin C 1.00 0.60 (0.80-0.71) 0.32 (0.44-0.38) 1.14 (1.48-1.31) 0.16 
Zinc 1.00 0.97 (0.51-1.86) 1.75 (0.96-3.22) 0.77 (0.39-1.51) 0.64 
 
                     Women                                                  Adjusted OR* with 95% CI 
Intake c 
Mg/1000Kcal/day 
1st  
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for  
Trend 
Vitamin A 1.00 1.42 (0.65-3.13) 1.84 (0.82-4.10) 2.06 (0.94-4.56) 0.10 
Carotene 1.00 0.70 (0.32-1.55) 1.15 (0.53-2.47) 1.39 (0.66-2.92) 0.88 
Vitamin E 1.00 1.08 (0.53-2.22) 0.62 (0.29-1.34) 0.80 (0.37-1.72) 0.52 
Vitamin C 1.00 1.74 (0.83-3.66) 0.56 (0.24-1.34) 1.45 (0.68-3.08) 0.61 
Zinc 1.00 0.90 (0.43-1.88) 1.11 (0.54-2.29) 0.72 (0.32-1.62) 0.77 
 
c Intake was categorised according to food quartile of daily consumption  
a
 Defined as at least one specific IgE concentration of >0.7  k U/l (RAST Class>2) 
*Adjusted for age, educational level, history of parental atopy, smoking habits, and body mass index 
OR: Odds ratio, CI: confidence intervals 
Bold fonts: indicate significance 
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Table 13. Associations Between Dietary Intake of Antioxidants and Hay Fever in 
Adults 
 
                     Men                                                      Adjusted OR with 95% CI 
Intake c 
Mg/1000Kcal/day 
1st  
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for  
Trend 
Vitamin A 1.00 1.40 (0.56-3.48) 0.77 (0.28-2.16) 1.95 (0.82-4.65) 0.44 
Carotene 1.00 0.48 (0.17-1.34) 0.98 (0.41-2.36) 1.36 (0.60-3.08) 0.80 
Vitamin E 1.00 2.80 (0.97-8.16) 4.06 (1.44-11.42) 1.66 (0.53-5.25) 0.04 
Vitamin C 1.00 0.72 (0.29-1.80) 1.20 (0.53-2.73) 0.74 (0.30-1.84) 0.72 
Zinc 1.00 1.93 (0.81-4.59) 1.65 (0.68-4.01) 0.54 (0.17-1.66) 0.45 
 
                     Women                                                Adjusted OR with 95% CI 
Intake c 
Mg/1000Kcal/day 
1st  
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for  
Trend 
Vitamin A 1.00 1.50 (0.50-4.46) 3.04 (1.10-8.45) 1.38 (0.45-4.27) 0.17 
Carotene 1.00 0.77 (0.27-2.16) 1.33 (0.51-3.45) 1.03 (0.39-2.76) 0.95 
Vitamin E 1.00 1.08 (0.41-2.85) 1.35 (0.53-3.44) 0.82 (0.30-2.28) 0.85 
Vitamin C 1.00 1.60 (0.64-4.03) 0.87 (0.31-2.43) 0.69 (0.24-2.00) 0.93 
Zinc 1.00 1.15 (0.45-2.94) 1.29 (0.51-3.25) 0.56 (0.19-1.67) 0.99 
 
c Intake was categorised according to food quartile of daily consumption  
a
 Defined as at least one specific IgE concentration of >0.7  k U/l (RAST Class>2) 
*Adjusted for age, educational level, history of parental atopy, smoking habits, and body mass index 
OR: Odds ratio, CI: confidence intervals 
Bold fonts: indicate significance 
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Table 14. Associations Between Dietary Intake of Antioxidants and Atopic Eczema 
in Adults 
 
                     Men                                                      Adjusted OR with 95% CI  
Intake c 
Mg/1000Kcal/day 
1st  
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for  
Trend 
 
Vitamin A 1.00 1.15 (0.62-2.12) 0.95 (0.51-1.80) 0.94 (0.50-1.78) 0.96 
Carotene 1.00 1.34 (0.72-2.50) 1.02 (0.54-1.94) 0.89 (0.46-1.72) 0.78 
Vitamin E 1.00 1.06 (0.56-2.02) 1.10 (0.58-2.08) 1.41 (0.75-2.63) 0.53 
Vitamin C 1.00 1.77 (0.89-3.52) 2.15 (1.10-4.22) 2.00 (1.02-3.91) 0.02 
Zinc 1.00 1.61 (0.86-3.00) 1.16 (0.61-2.20) 0.98 (0.50-1.89) 0.44 
 
                     Women                                                   Adjusted OR with 95% CI 
Intake c 
Mg/1000Kcal/day 
1st  
Quartile 
2nd 
Quartile 
3rd 
Quartile 
4th 
Quartile 
P for  
Trend 
Vitamin A 1.00 0.78 (0.39-1.56) 0.72 (0.36-1.47) 0.95 (0.48-1.90) 0.48  
Carotene 1.00 0.83 (0.41-1.71) 1.45 (0.72-2.88) 0.86 (0.42-1.77) 0.95  
Vitamin E 1.00 0.97 (0.49-1.90) 0.52 (0.25-1.08) 1.08 (0.55-2.12) 0.51  
Vitamin C 1.00 1.29 (0.65-2.54) 0.82 (0.40-1.65) 0.57 (0.27-1.18) 0.60  
Zinc 1.00 1.34 (0.67-2.71) 1.13 (0.55-2.30) 1.32 (0.65-2.72) 0.44  
 
c Intake was categorised according to food quartile of daily consumption  
a
 Defined as at least one specific IgE concentration of >0.7  k U/l (RAST Class>2) 
*Adjusted for age, educational level, history of parental atopy, smoking habits, and body mass index 
OR: Odds ratio, CI: confidence intervals 
Bold fonts: indicate significance 
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4 Discussion 
 
4.1 Methodology 
 
 In cross-sectional studies the time frame between exposition and the disease 
expression is considerable, therefore causality can not be demonstrated. Nonetheless, 
this epidemiological design allows the postulation of hypothesis based in description of 
the prevalence of any given condition in a study population, delivering valuable 
evidence and setting the basis for further research. The instruments of data collection 
(ECRHS and MONICA study) as well as the methodology were validated. All data were 
checked for plausibility. Although three day weighed records have some limitations, as 
do all other dietary assessment methods, they allowed precise nutrient calculations. 
(Table 15/Attachments ). 
 
4.2 Study Relevance  
 
 This study suggests that dietary fat intake is associated with the risk for allergic 
sensitisation and disease manifestation, with somewhat different findings in men and 
women. In both men and women, there were indications for an increased risk with a 
high intake of omega-6 and a low intake of omega-3 fatty acids. In women, also total fat 
and high monounsaturated fatty acids intake were associated with an increased risk of 
suffering atopic manifestations. This data adds to the limited epidemiological evidence 
available on associations between dietary habits and atopic disease prevalence. Most 
of the published studies were conducted in children, and dietary intake was assessed 
using simple food item lists, not always well validated, or on an aggregated level. 
Previous epidemiological studies in Germany used data on preferred types of bread 
spread as surrogate for the type of consumed fat and without specific fatty acid 
determination. They did not consider that the total fat intake from the diet may influence 
the immune response.7-8-9-49 
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4.3 Fat and Fatty Acids Intake 
 
 Our finding a relation of margarine consumption to hay fever prevalence in males 
is consistent with the findings from a cross-sectional study conducted in children.7 Also, 
results from a Japanese study support the role of polyunsaturated fatty acids intake, 
assessed with a food frequency protocol, in the aetiology of seasonal allergic-
rhinoconjunctivitis in women.9 High levels of omega-6 fatty acids may alter the immune 
response favouring the synthesis of pro-inflammatory mediators, thus enhancing the 
response to allergens.2 Moreover, the ratio of omega-6 to omega-3 fatty acids as well 
as the supply of the omega-6 metabolite arachidonic acid were reported to modulate 
cell membrane composition, gene expression, gut permeability and the activity of the 
lymphocytes and macrophages, as well as enhancing IgE production.2-49-50-51-52 
 In most published studies, the intake of total and omega-6 polyunsaturated fatty 
acids intake was inferred from margarine consumption.1-2-7 Depending on the conditions 
of its production, margarine is usually a good source of omega-6 polyunsaturated fatty 
acids, but is often also rich in monounsaturated and trans-fatty acids. We did not 
analyse potential effects of trans fatty acids since no reliable information on trans fatty 
acids was available from the German Food Composition Database. Trans fatty acids 
appear to impair the desaturation of linoleic acid and α-linolenic acid to their long chain 
metabolites.53 Results from a European ecological study support the hypotheses that 
high monounsaturated fatty acids intake might promote the development of allergic 
sensitisation.10 We found these similar effects in women, such as an association of 
specific high IgE concentration with high monounsaturated fatty acids intake, and also 
with high total fat and SFA consumption. Moreover, we found a positive association 
between the intake of the two major monounsaturated fatty acids, palmitoleic and oleic 
acids, in relation to allergic sensitisation. Consistently, high fat intakes, a high 
monounsaturated fatty acid intake—specifically a high consumption of oleic acid—were 
also associated with hay fever. New evidence is also consistent with these findings. A 
very recent paper on data of a German prospective study provided further evidence of a 
positive association between high intake of oleic acid with hay fever prevalence.23 This 
research group speculated that the intake of oleic acid correlates with a high intake of 
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trans fatty acids because both are delivered by  the same food sources.23 Kompauer et 
al., in a publication posterior to this study, analyzed the blood samples of the ECRHS 
population, and as a result, corroborated the positive association between allergic 
sensitisation and oleic acid levels in serum phospholipids. Also consistently with the 
present epidemiological findings, the positive association between hay fever and seric 
arachidonic acid was also confirmed.54 Our data suggests that a high consumption of 
alpha linolenic acid was negatively associated with the prevalence of eczema. Horrobin 
formulated the hypothesis that atopic eczema may be a minor inherited abnormality of 
EFA metabolism. Thus, atopic eczema may be linked to different pathophysiological 
mechanisms rather than other atopic manifestations. 55 
Due to the low fish intake of the analysed sample, this study was unable to find 
an inverse association between fish consumption and atopic disease, such as observed 
in the epidemiological study of Haby and Peat.8 Subsequently, no associations between 
omega-3 fatty acids consumption and atopic disease were found.  
 This study was unable to determinate any association between dietary fat, 
asthma and BHR. The low prevalence of self-reported doctor’s diagnosis of asthma in 
the study sample impeded the application of multiple statistical tests. Additionally, the 
lack of significant associations between BHR and fatty acid intake may be related to the 
reduced number of participants on the methacholine provocation test, thus causing a 
loss of statistical power. 
 
4.4 Fruit, Vegetable and Antioxidants Intake 
 
As another potential covariable, a decreased fruit and vegetable consumption 
with a low intake of antioxidants was suggested to be associated with recent increases 
in asthma prevalence.12-15-56 According to the present data, high vegetable consumption 
showed an inverse association with allergic sensitisation in men. Similarly, in women, a 
moderate and a normal vegetable products intake was also inversely associated with 
allergic sensitisation. Data to compare those findings are scarce. Heinrich et al. found in 
an ecological study an inverse association between mean fruit intake and the 
prevalence of allergic sensitisation.10 Deveraux et al. affirmed that dietary intake of fruit, 
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antioxidant vitamins, and selenium is increasingly being associated with a reduced 
prevalence of asthma and wheezing syndromes.12 A French study conducted in women, 
suggested that the intake of some vegetables may decrease the prevalence of adult 
asthma.16 Among children, consumption of fresh fruit, particularly fruit high in vitamin C, 
has been related to a lower prevalence of asthma symptoms and higher lung function. 
This effect was observed even at low levels of fruit consumption (one or two servings 
per week vs. less than one serving per week), which suggests that a small increase in 
the dietary intake could have a beneficial effect in this group.57 Further studies among 
children and young adults have consistently shown a positive impact of fresh fruit and 
vegetable intake, although the type of beneficial foods varies across studies.17 Some 
evidence is available for vitamin E and C; their low consumption is related to increased 
prevalence and incidence of asthma, wheezing, lower levels of lung function and hay 
fever.1-12-20-23 A recent German study observed a negative association between high 
plasma carotenoids levels and the prevalence of allergic rhinitis and gamma-tocopherol 
concentration with allergic sensitisation.58 
 Despite the observed negative association between high vegetable intake and 
sensitisation, which allows to hypothesize that antioxidants constituents of vegetables 
and fruit may protect against atopic diseases, this study failed to demonstrate any 
association between vitamin A, carotene, vitamin C, and vitamin E intake and allergy 
outcomes variables as sensitisation and hay fever in both analyzed strata. Conversely, 
vitamin C has been shown in several cross-sectional and case-controlled studies to be 
associated with a reduced asthma risk. However, a large intervention study on vitamin 
C among adults failed to demonstrate any protective effect of vitamin C.58 The lack of 
findings in this study could reflect some food composition data limitations.  
Furthermore, other potent antioxidants and mineral constituents of vegetables 
and fruits, such as selenium, iron, manganese, and flavonoids, may influence the 
immune response and were not assessed.60-61 Three-day records may have limitations 
in reflecting habitual antioxidants consumption, due to the irregular intake among the 
days and seasonal variations of fruit and vegetable availability. The variability of 
protective foods across published studies might also be linked to different dietary 
patterns characteristic of the studied populations.  
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 The positive association computed for high vegetable intake, vitamin C and 
atopic eczema could be a proxy variable, denoting that men who are suffering skin 
lesions follow a healthier diet. We consider unlikely that the observed OR indicates a 
possible specific food allergy association. 
 
4.5 Gender Differences  
 
 Most statistically significant effects in relation to fat consumption and allergic 
disease in our study were limited to women. Gender-specific dietary patterns might 
partly explain the observed differences. In our study, significantly higher consumption 
of? absolute butter, margarine in men were observed. In addition, the development of 
atopic diseases may underlie different gender-linked physiological mechanisms. 
Furthermore, we could not exclude that the lower participation rate in women induced 
bias. 
 We did not consider alcohol consumption as confounder, which is usually 
markedly higher in men and might enhance oxidative stress and modulate immune 
responses.17-21  
 
4.6 Ongoing Related Research 
 
 The possible modulating role of the intestinal microflora, the dietary intake of 
non-digestible carbohydrates that serve as substrates for colonic bacteria, and of 
intestinal trophic factors has received increased attention following indications that 
administration of specific lactobacilli in early life may reduce the risk of atopic 
dermatitis.62 Thus, the effects of dietary components other than fat and antioxidants 
intake on the immune response needs to be considered in further evaluations. Another 
promising field of research focuses on the importance of antenatal nutrition in the 
development of atopy later in life. Deveraux et al. recently delivered reliable evidence 
pinpointing that dietary modification or supplementation with vitamin E, vitamin C, and 
zinc during pregnancy modifies the risk of developing childhood asthma and eczema.63- 
64 Emerging evidence suggests that exposures during pregnancy and the early 
postnatal period can modify gene expression and disease propensity, suggesting that 
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early exposures to dietary immunomodulatory factors, including PUFA, may shape the 
development of atopic disease 65-66-67-68 A prospective study concluded recently that the 
development of atopic diseases in early childhood is associated with prenatal exposure 
to n-6 vs. n-3 fatty acids, but also observed inconsistencies between different atopy 
manifestations. 69 
Innovative research is focusing on common genetic variations, evidencing the presence 
of polymorphisms in the fatty acid desaturase gene cluster, affecting the PUFA and LC-
PUFA status on humans. 70-71 
Finally, based on the analysis of fatty acids in serum phospholipids from this same 
studied population, new findings emerged. Results were consistent with the present 
study showing positive associations between hay fever and arachidonic acid, and also 
between allergic sensitisation and oleic acid. An analysis of the association of fatty 
acids in serum phospholipids with lung function and bronchial hyperresponsiveness 
established that a high concentration of docosahexaenoic acid in serum phospholipids 
may have a protective effect on lung function. Moreover, no association between the 
n6/n3-ratio in serum-phospholipids and hay fever or allergic sensitization was 
observed.72-73-74 
 
4.7 Conclusion 
 
 Given the large number of associations tested in this study, some of the founded 
effects may be due to chance. However, we hypothesize that consistency across 
outcome measurements, such as atopic sensitisation and hay fever, and independent 
effects observed between highly correlated fatty acids intake and atopy outcomes, 
reflect a valid pattern of associations.  
 Based on the results of this study and previously published results, we 
hypothesize that an excess of fat or imbalance in fat intake, particularly of 
monounsaturated fatty acids, could alter immune function and increase the risk of an 
allergic reaction. This data cannot demonstrate a causal association between fat 
consumption and atopy, in which case diet would be a modifiable risk factor and dietary 
manipulation might serve as a useful tool in public health programs oriented to prevent 
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and treat allergic disease. The development of dietary guidelines for the population in 
general and for individuals at risk of suffering atopic disease would be a challenge. 
The complexity of this topic requires further scientific investigations. Prospective 
intervention trials would offer an opportunity to investigate these hypotheses, which hold 
a great potential for health prevention strategies. 
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5 Abstract  
 
It was hypothesized that high fat consumption, specifically from polyunsaturated 
fatty acids, may be positively related to atopic disease prevalence. On the other hand, 
antioxidants constituents of the diet may exert a protective effect against disorders 
related to the immune system. 
The aim of the present cross-sectional study was to assess the relationship 
between dietary intake of selected foods, fatty acids, and dietary antioxidants with 
atopic disease prevalence in adults. 
Data from the European Community Respiratory Health Survey in Erfurt, 
combined with a three-day weighed records from the MONICA dietary survey, was 
used. Complete data was available from 469 men and 333 women aged between 20 
and 64 years. Multiple logistic regression was applied comparing the highest with the 
lowest quartile of dietary exposures and linear trends were tested stratified by gender. 
In men, margarine intake and a high ratio of omega-6 to omega-3 fatty acids were 
positively associated with hay fever (p for trend 0.03 and 0.04 respectively). In women, 
a high intake of total fat, palmitoleic and oleic acids were positively associated with 
sensitisation (aOR 2.42, p for trend 0.11, 3.04, p for trend 0.02, 2.47, p for trend 0.03 
respectively). A high total fat (aOR 4.51, p for trend 0.05), high monounsaturated fatty 
acids (aOR 3.04, p for trend 0.01), and high oleic acid consumption (aOR 4.99, p for 
trend 0.01) were positively associated with hay fever.  
 No clear relationships between antioxidant nutrients consumption and allergic 
disease were observed. 
Whilst an excessive intake of fat or imbalance in fat intake, particularly of 
monounsaturated fatty acids, increased the risk for hay fever and allergic sensitisation 
in women. Mainly, no significant associations were found for men. Dietary factors were 
mostly not related with prevalence rates of bronchial hyperresponsiveness and atopic 
eczema neither in men nor in women.   
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5 Zusammenfassung 
 
Es besteht die Hypothese, dass eine hohe Fettaufnahme, besonders von mehrfach 
ungesättigten Fettsäuren, positiv mit der Prävalenz von atopischen Erkrankungen 
korreliert. Andererseits könnte die Aufnahme von Antioxidantient aus der Nahrung 
gegen immunassozierte Störungen protektiv wirken. 
Ziel der vorliegenden Querschnittstudie ist, den Zusammenhang zwischen der 
Einnahme ausgewählter Nahrungsmitteln, Fettsäuren und Antioxidantien aus der 
Nahrung sowie die Prävalenz von atopischen Erkrankungen bei Erwachsenen zu 
evaluieren. 
Daten von der Europäischen Studie zur Prävalenz von Atemwegserkrankungen in 
Erfurt, zusammen mit von der MONICA Ernährungsuntersuchung stammenden drei 
Tage-Wäge-Protokolle wurden analysiert. Vollständige Daten von 469 Männern und 
333 Frauen im Alter von 20 bis 64 Jahren wurden erfasst. Geschlechtstratifizierte 
multiple logistische Regressionmodelle inklusive lineare Trends wurden vorgenommen, 
um die höchste und niedrigste Einnahmequartile der diätetischen Exposition zu 
vergleichen.  
Die Prävalenz von Heuschnupfen wurde sowohl mit der Margarinaufnahme als auch mit 
einem hohem Omega-6 zu Omega-3 Fettsäurenratio bei Männern positiv assoziiert 
(beziehungsweise, p für Trend 0,03 and 0,04).  
Bei Frauen wurde eine hohe Gesamtfettaufnahme sowie ein erhöhter Palmitoleinsäure- 
und Ölsäureverzehr mit allergischen Sensibilisierung positiv assoziiert (bzw. aOR 2,42, 
p für trend 0,11; 3,04, p für trend 0,02; 2,47, p für trend 0,03). Ein hoher Verzehr von 
Gesamtfett-, einfach ungesättigtet Fettsäuren und Ölsäure wurde mit der 
Heuschnupfenprävalenz positiv verbunden. 
Es wurden keine eindeutigen Zusammenhänge zwischen der Aufnahme von 
Antioxidantienten aus der Nahrung und allergischen Erkrankungen festgestellt. 
Während bei Frauen eine überhöhte Zufuhr von Fett oder eine unausgeglichene 
Fettaufnahme, insbesondere der einfach ungesättigten Fettsäuren das Risiko für 
Heuschnupfen- und  allergische Sensibilisierung inkrementieren, wurden bei Männern 
meistens keine signifikante Assoziationen gefunden. 
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Weder bei den Männern noch bei den Frauen bestand ein Zusammenhang 
zwischen diätetische Faktoren und der Prävalenz von bronchialen Hyperreaktivitäts- 
und atopischen Ekzem.   
 
 Acknowledgements  
56 
 
6 Acknowledgements 
 
Hiermit möchte ich mich bei Dr. J. Heinrich im GSF für seine wertvolle Hilfestellung und 
unermüdliche Betreuung bedanken. Ohne seine Ideen und sein Vertrauen in mich wäre 
diese Arbeit nicht zu Stande gekommen. Meine Annerkennung auch an Frau A. Döring, 
die mir die Ernährungsepidemiologie näher gebracht hat. 
 
Ich danke allen Mitarbeitern der Abteilung für Stoffwechselkrankheiten und 
Ernährungsmedizin des Dr. von Haunerschen Kinderspitals, sie haben durch ihre 
Unterstützung und die exzellente Arbeitsatmosphäre meine Aufgabe erleichtert. 
 
Besonderen Dank an Frau. Dr. K. Dokoupil die tagtäglich ihre Vision und Kenntnisse 
der Ernährungswissenschaft mit mir grosszügig geteilt hat. Danke auch an Frau C. 
Berger, sie ist die stille Kraft hinter mehreren Anstrengungen. Meine ganz ehrliche 
Dankbarkeit an Herrn Prof. Koletzko für die angebotene Gelegenheit die Promotion 
durchzuführen. Er wird mit seiner Leidenschaft für die vielfaltigen Aspekte der 
Wissenschaft, endlose Energie und Enthusiasmus immer ein Vorbild und in Erinnerung 
bleiben. 
 
Zuletz gilt mein Dank meiner Familie und allen meinen Freunden die mir stets zur Seite 
standen.
Glossary 
57 
 
7 Glossary of common terms 
 
Allergen: the source of an allergy-producing substance, the allergy-producing 
substance itself, or one or more of the specific proteins that make up the substance and 
provoke the immune response, including IgE antibodies. They are often common, 
usually harmless substances such as pollen, mold spores, animal dander, dust, foods, 
insect venoms, and drugs. 
 
Allergic diseases: represent the clinical manifestations of adverse immune responses 
(including IgE responses), following repeated contact with usually harmless substances 
such as pollen, mold spores, animal dander, dust, foods, insect venoms, and drugs; 
include diseases of the atopic diathesis as well as diseases which may have an allergic 
component. 
 
Allergic sensitisation: outcome variable defined as at least one specific 
immunoglobulin E concentration of ≥0.7 k UL- (radioallergosorbent test class ≥2). 
 
Asthma: is a chronic inflammatory disease of the airways characterized by airway 
obstruction which is at least partially reversible with or without medication, and 
increased bronchial responsiveness to a variety of stimuli. 
 
Atopy: the genetic tendency to develop the “classical” allergic diseases, namely, 
allergic rhinitis, asthma, and atopic dermatitis. Atopy is typically associated with a 
genetically determined capacity to mount IgE responses to common allergens, 
especially inhaled allergens and food allergens. 
 
Bronchial hyperresponsiveness: increased bronchial responsiveness was defined as 
20% or greater fall in baseline forced expiratory volume in one second before a maximal 
cumulative dose of methacholine (2 mg) was administered. 
 
Eczema: is an inflammatory disease of the skin with lesions that can be erythematous, 
edematous, papular, crusting, lichenified, scaling, itching, or burning. Sometimes skin 
discoloration can occur. 
 
Hay fever: is an IgE-mediated reaction of the nasal mucosa to one or more seasonal 
allergens, characterized by inflammation of the mucous membranes of the nose with 
symptoms of sneezing, itching, nasal discharge, and congestion 
 
Spirometry (FEV1): pulmonary measurements made with a spirometer to evaluate 
airway obstruction, and if so, whether it is reversible with a bronchodilator. It is 
mandatory to diagnose and characterize asthma severity. 
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Table 15. Advantages and Disadvantages of the Prospective Three-Day Dietary 
Intake Records. 
 
Advantages Disadvantages 
• The study subject is not required to 
recall food intake, thus avoiding 
memory deficiencies. 
 
• Timeframe is predefined. 
 
 
• Consumed and wasted food is 
accurately recorded. 
 
• Allows precise nutrient intake 
calculations. 
 
 
• Food habits could be described. 
 
 
• Involves a high commitment level 
from the participant. 
• Demands more financial resources 
as well as intensive time investment. 
• Health-conscious subjects could be 
overrepresented. 
• Out-of-home consumption is often 
inaccurately recorded. 
• Unfeasible in prolonged study time 
or larger populations. 
• Trained observers are requested. 
• Food intake could be altered, 
especially while the subject is aware 
of being observed. 
• Coding of the items for data 
management is work-intensive. 
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Table 16. Selected Epidemiological Studies Evidencing Relationships Between Nutrient Intakes and Atopic Diseases. 
 
BMI: Body Mass Index, ECRHS: European Community Respiratory Health Survey, MUFA: monounsaturated fatty acids, PUFA: polyunsaturated fatty acids, FFQ: 
Food frequency questionnaire, (+): positive association, (-): negative association. 
Authors/Country Publication Study Design 
Study 
Population/Age 
range 
Method of 
Data 
Collection 
Outcome Considered Confounders Results 
Haby, Peat. 
 
Australia 
Thorax 
2001 
Cross-
sectional 
Children 
(3-5 years) 
n=974 
Questionnaire/ 
Fat intake 
Asthma 
(Diagnosed by a 
physician/symptomatic in 
the last 12 months)  
Atopy /Prick test 
(as co-variable) 
Number of siblings 
Infections 
Atopy(+) 
Infections(+) 
PUFA(+) 
Number of 
siblings(-) 
Breast 
feeding(-) 
 
Wakai, 
Okamoto 
 
Japan 
 
 
AEP 
2001 
 
 
Cross-
sectional 
 
Women (nurses) 
(22-57 years) 
n=1012 
 
Questionnaire/
FFQ 
 
Seasonal Allergy  
(Rhinoconjunctivitis) 
 
 
Age, genetic 
predisposition, 
diagnosed atopy, 
smoking 
 
 
PUFA(+) 
Bolte, Frye 
 
Germany 
 
Am J Respir 
Crit Care Med. 
2001 
 
Cross-
sectional 
 
Children 
(5-14 years)  
n=2348 
 
Questionnaire/ 
Fat intake 
 
Sensitisation (Rast I ) 
Rhinitis 
 
Age, living 
conditions, 
educational level of 
the parents, 
number of siblings, 
BMI 
 
 
Margarine(+) 
 
 
Heinrich, Hölscher 
 
Germany 
 
 
Eur Resp 
2001 
 
Ecological  
Study 
 
Adults 
n=3872 
 
ECRHS 
Dietary 
Surveys 
(records or 
recalls) 
8 Centers 
 
Sensitisation  
 
 
Age, gender 
 
MUFA(+) 
 
Fruits(-) 
Barth, Weigl 
 
Switzerland 
 
Eur J Derm 
2001 
 
Cross-
sectional 
 
Adults 
n=116 
 
FFQ 
 
Atopic Dermatitis 
(symptomatic) 
 
? 
Nuts(+) 
Milk products, 
Fish, Eggs, 
Fruits (-) 
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